Patent Publication Number: US-2022235370-A1

Title: Polynucleotides, primers, and methods for detection of transgenic event, genetic construct, kit for detection material from a plant sample, event ctc91087-6, insect-resistant sugarcane plant, and method for producing an insect-resistant sugarcane plant, plant cell, plant part or seed

Description:
TECHNICAL FIELD 
     The present invention relates to the field of biotechnology. More specifically, there is described a genetic construct and a method for producing a transgenic plant event, especially a sugarcane ( Saccharum  spp.) event, which expresses the Cry1Ac toxin conferring resistance to infestation by the pest  Diatraea saccharalis , popularly known as common borer, cane borer or just borer. The invention describes a method for detecting the event and material derived from the event resistant to cane borer infestation, as well as polynucleotides, primers, probes and the flanking regions identifying such an event. 
     BACKGROUND 
     Sugarcane ( Saccharum  spp.) is a grass belonging to the botanical family Poaceae, originating from Southeast Asia, more precisely from the large central region of New Guinea and Indonesia. It is one of the most important plant species grown in the tropical and subtropical regions, with an area of over 23 million hectares spread over 121 countries (FAO Statistical Yearbook 2012 p. 233). 
     Sugarcane is a source of raw material for the production of sugar, wine, molasses, rum, cachaça (Brazil&#39;s national distillate) and ethanol for fuel. The bagasse that is produced after the sugarcane milling can be used for baling, supplying heat energy, processing at mills, producing electricity (that is typically sold to the consumer&#39;s electric grid), or as raw material for the production of sugarcane second-generation ethanol (BR 11 2014 02385-1). Thus, the sugarcane agro-industry has great economic and social importance by generating millions of jobs in the area and fostering foreign exchange through the commercialization of sugar and ethanol and sustainable and optimal use of plant biomass. 
     More recently, with the advent of global warming and the subsequent desire for alternatives to fossil fuels (biofuels), worldwide interest in sugarcane has increased significantly. The use of sugarcane-based ethanol as a renewable energy source has been considered extremely important for reducing greenhouse gases and dependence on fossil fuels, thus making it a key element in efforts to control global climate change (Savage, 2011). 
     Due to the economic and social importance of sugarcane, an increasing amount of research has been directed toward defining best agricultural practices for its cultivation and improving the quality of cultivated varieties. Efforts to improve sugarcane agronomic characteristics have focused on increasing sugar production and accumulation, increasing tolerance to biotic and abiotic stresses, resistance and tolerance to pests and pathogens, and developing alternative technologies for the production of sugarcane ethanol from lignocellulosic biomass (PI 0802153-8; PI 0904538-4; PI 1101295-1). 
     The complexity of the polyploid and aneuploid genome of modern sugarcane varieties, coupled with their relatively restricted genetic base and low fertility, impose great difficulties and numerous limitations on the selection of plants with desirable agronomic characteristics using conventional breeding (Souza et al, 2011; D&#39;Hont &amp; Glaszmann, 2005, Basel, v. 109, no. 1-3, p. 27-33; Cheavegatti-Gianotto et al., 2011). Therefore, high production costs, the necessity of manual labor, and long product-to-market timelines may prevent the sugarcane industry from meeting the growing demands of the global market. 
     Due to the limitations of conventional breeding methods and the increasing need to rapidly and efficiently incorporate desirable traits, the use of genetic engineering (biotechnology) in sugarcane breeding programs has gained prominence, in particular due to the commercial success of incorporating desirable agronomic traits through genetic engineering into other plant species (soybean, corn, canola, beet and cotton, for example). 
     Plant genetic engineering involves the transfer of genes-of-interest into plant cells (genetic transformation) in such a way that a fertile and agronomically superior progeny maintain and stably express the gene responsible for the desired trait. 
     Despite the potential of sugarcane genetic alteration (incorporation of desirable characteristics) by genetic engineering [virus resistance (Guo et al., 2015; Zhu et al., 2011), insects (Kalunke, Kolge, Babu, &amp; Prasad, 2009; Weng et al., 2011), herbicides (Enriquez-Obregon, Vazquez-Padron, Prieto-Samsonov, De la Riva, &amp; Selman-Housein, 1998; van der Vyver, Conradie, Kossmann, &amp; Lloyd, 2013), drought tolerance (Molinari et al., 2007; Reis et al., 2014), salinity (Kumar, Uzma, Khan, Abbas, &amp; Ali, 2014) and aluminum toxicity (Ribeiro, 2016), increased production and accumulation of sugar (Bewg, Poovaiah, Lan, Ralph, &amp; Coleman, 2016; Mudge et al., 2013)], this approach is limited by intrinsic characteristics of sugarcane. Unlike maize, rice, wheat and other commercial cereals, sugarcane exhibits difficulties in tissue culture propagation, low rates of induction and regeneration of embryogenic calluses, and the impossibility of using the zygotic embryo as a target tissue in genetic transformation [(Anderson &amp; Birch, 2012; Basnayake, Moyle, &amp; Birch, 2011; Molinari et al., 2007)]. Low rates of transformation efficiency and high variability between sugarcane genotypes are frequently observed, and there are still numerous challenges to overcome in order to successfully incorporate desirable agronomic traits into sugarcane using genetic engineering. 
     Sugarcane is considered a recalcitrant species for genetic transformation, and although several genetic engineering approaches have been evaluated for this species, there are still no standard protocols that guarantee the production of transgenic events (Smith et al. 1992; Rathius &amp; Birch 1992; Chen et al. 1987; Arencibia 1998; Manickavasagam et al. 2004; Elliott et al. 1998). 
     In addition to the inherent limitations of the species that prevent the application of existing genetic engineering techniques, the complexity of the sugarcane genome (high ploidy level and aneuploidy), prevents trait introgression into specific cultivars through backcrossing (reconstitution of a specific genotype), as is commonly performed in other crops of commercial interest. 
     The genotypic complexity of the species also significantly impacts the characterization of the events generated in order to ensure the necessary characteristics for their commercialization. The unambiguous identification of transgenic events is fundamental to ensure their traceability and monitoring, which is a regulatory requirement for their commercialization. The high polyploidy of the sugarcane genome and the high number of repeated regions, coupled with the lack of information on their organization and structure, make the characterization of the transgenic events generated even more difficult. 
     There are several technical challenges to be overcome in the field of sugarcane breeding to increase the predictability of results, even when applying widely known conventional and/or molecular/genetic techniques. Despite all the technical challenges for obtaining more productive varieties of sugarcane, there is no doubt about the urgency of obtaining improved varieties that have characteristics that significantly impact crop productivity and therefore its market. 
     Historically, agricultural pests are one of the main factors that cause losses in agriculture. In Brazil, the main sugarcane pest is the species  Diatraea saccharalis  (first described by Fabricius in 1794), popularly known as the common borer, cane borer or just borer. It is a member of the Crambidae family and  Lepidoptera  order. The borer is found practically everywhere the crop is cultivated, an area of approximately 10 million hectares for the 2019/20 crop season (CONAB, 2019). 
     After mating, the female sugarcane borer lays 200 to 400 eggs distributed on either side of the leaves as well as the leaf sheaths. After hatching, neonate larvae feed on the leaf parenchyma, migrating to the sheath region for shelter. They remain in this region for 7 to 10 days, feeding by scraping the leaf sheath or bark of the young internodes. After an ecdysis, the caterpillars pierce the stem, penetrating inside. The insect creates tunnels inside the stem, usually upwards as it feeds. Inside the culm, the caterpillar goes through approximately six ecdyses before becoming a winged adult (DINARDO-MIRANDA, 2014). This is the developmental stage of the insect that causes economic damage to the crop ( FIG. 1 ). 
     The attack of the sugarcane borer also causes serious secondary damage to the quality of the raw material used for sugar and alcohol production, because the drilling of the sugarcane stem by the borer creates favorable conditions for fungal entry and opportunistic bacteria, especially  Fusarium  moniliform and  Colletotrichum falcatum , causing red rot ( FIG. 2 ). Bacteria associated with the red rot raw material produce undesirable fermentations, resulting in products foreign to industrial alcoholic fermentation. Moreover, these bacteria also produce organic acids and gums (dextrans) from the sugars contained in the wort, which negatively affect the viability of yeast cells, requiring their replacement in fermentation reactors (Prececti and Terán 1983; Prececti et al., 1988; BOTELHO and MACEDO, 2002). Another problem arising from the presence of bacteria in fermentation reactors is the possibility of yeast flocculation occurring. In this case, the contaminating bacteria form mucilage that aggregates the yeast cells, causing them to flocculate. Finally, plants attacked by the borer/red rot complex also have high levels of phenolic compounds (METCALF and LUCKMANN, 1994; PRICE, 1997). 
     Assuming a 4% borer Infestation Infection Index (typical for Brazilian sugarcane fields), average agricultural losses, and pest control costs, it is estimated that the borer causes economic losses of more than R$5 billion annually to the sugar and ethanol production industries. 
     The sugarcane borer is difficult to control with chemical insecticides due to the feeding behavior of the larva in the stem, which prevents the insecticide from effectively contacting the insect. As an alternative to chemical insecticides, insecticidal proteins, mainly identified from the bacterium  Bacillus thuringiensis  (Bt), have been used to control agricultural pests, including  Diatraea  sp. Among the insecticidal proteins derived from Bt strains, Cry crystalline proteins stand out for their specific toxicity to larvae of common lepidopteran, dipteran and coleopteran species. These proteins, produced as protoxins (65-149 KDa), are solubilized and activated in the intestines of susceptible insects by proteolysis and bind to the intestinal cell membrane, inducing osmotic lysis of the epithelium, which causes the insect to die. 
     Cry proteins are classified into several groups according to sequence homology, among them, the protein group classified as Cry1 presents high specificity against lepidopteran insects, making it an excellent candidate for introduction into sugarcane germplasm to produce sugarcane borer resistant varieties. The heterologous expression of Cry1 proteins in sugarcane varieties, although challenging, has great potential for sugarcane borer control, reducing economic losses to the sugarcane industry, as well as the release of chemical insecticides in the environment. 
     Therefore, there remains a need to develop strategies to mitigate the damage caused to sugarcane crops by pest infestation, especially by infestation by the sugarcane borer pest. By offering sugarcane growers varieties with both high yield potential and borer resistance traits, agricultural biotechnology makes an important contribution to the sugarcane industry and Brazilian sugarcane growers. 
     Embodiments 
     In a first embodiment the invention provides polynucleotides that unambiguously identify the event CTC91087-6. 
     The invention also identifies primers pairs and probes able to identify polynucleotides that characterize the event CTC91087-6. 
     In a third embodiment the invention provides methods for detecting plant material derived from the CTC91087-6 event. 
     Other embodiment of the invention defines a kit for detecting the presence of event CTC91087-6 in a sample of plant material. 
     The fifth embodiment of the present invention is a genetic construct capable of imparting to a sugarcane ( Saccharum  spp.) plant, resistance to insect infestation, particularly by  Diatraea saccharalis  pest. 
     Also, the invention provides a genetically modified sugarcane, a plant part, plant cell, plant tissue, or seed comprising the genetic construct of interest located at a site defined in the genome of the transformed sugarcane plant, characterized by specific flanking sequences. 
     The seventh embodiment of the present invention is to provide a commodity product. 
     The eighth embodiment of the present invention is a method of producing an insect resistant plant. 
     Finally, the ninth and tenth embodiments of the invention are to provide a method of making and cultivating an insect resistant sugarcane plant and/or plant cell, plant part, or seed. 
     SUMMARY OF THE INVENTION 
     The first embodiment is achieved by providing polynucleotides comprising at least 14 to 26 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 5, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 18, SEQ ID NO: 19, and SEQ ID NO: 22. 
     The second embodiment of the invention is achieved by providing primers pairs wherein the forward primer consists of SEQ ID NO: 6 and the reverse primer consists of SEQ ID NO: 7 and/or the forward primer consists of SEQ ID NO: 8 and the reverse primer is SEQ ID NO: 9. 
     The third embodiment is achieved by a method of detecting plant material derived from event CTC91087-6 comprising the steps of:
         a) obtaining a sample for analysis;   b) extracting DNA from the sample;   c) providing primer pairs comprising at least a forward and a reverse primer;   d) amplifying a region between the primer pair; and detecting the presence of a product from amplification.       

     Also to achieve the third embodiment the primer pairs in step c) are designed to bind to a polynucleotide comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 22 and SEQ ID NO: 29, wherein at least one pair of primers comprises contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31. 
     Still to achieve the third embodiment, the present invention describes a method of detecting plant material derived from event CTC91087-6 comprising the steps of:
         a) obtaining a plant material sample for analysis;   b) extracting DNA or RNA from the sample;   c) providing a probe designed to bind to the complement of a polynucleotide comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33;   d) hybridizing said probe with the sample; and   e) detecting the actual hybridization of the probe.       

     The fourth embodiment of the invention is evidenced by a kit for detecting the presence of event CTC91087-6 in a plant sample, the kit comprising a means to detect the presence of a polynucleotide comprising, at least, 14 contiguous nucleotides of SEQ ID NO: 18 and/or of SEQ ID NO: 19 and/or a pesticidal crystal protein (Cry). 
     The fifth embodiment is achieved through providing a genetic construct comprising SEQ ID NO: 1. 
     The sixth embodiment is achieved through a genetically modified sugarcane ( Saccharum  spp.) plant, a plant part, plant cell, plant tissue, or seed comprising SEQ ID NO: 18 or SEQ ID NO: 19. 
     The seventh embodiment is achieved by providing a commodity product produced from the genetic modified sugarcane from the present invention. 
     The eighth embodiment is achieved by a method of producing an insect resistant plant comprising SEQ ID NO: 20 and SEQ ID NO: 21 
     The ninth embodiment of the present invention provides a method of making an insect resistant sugarcane plant comprising introducing a genetic modification to a sugarcane ( Saccharum  spp.) plant comprising SEQ ID NO: 5 or SEQ ID NO: 22 to produce a genetically modified sugarcane ( Saccharum  spp.) plant of event CTC91087-6. 
     Finally, the tenth embodiment of the invention describes a method of cultivating a genetically modified sugarcane ( Saccharum  spp.) plant of event CTC91087-6, comprising growing a genetically modified sugarcane ( Saccharum  spp.) plant of event CTC91087-6 comprising SEQ ID NO: 5 or SEQ ID NO: 22 under conditions comprising insect infestation. 
    
    
     
       BRIEF DESCRIPTION OF THE FIGURES 
         FIG. 1  exemplifies the damage to sugarcane stalks caused by  D. saccharalis  (sugarcane borer). 
         FIG. 2  exemplifies the red rot-borer complex due to  D. saccharalis  (cane borer) attack. 
         FIG. 3  represents the map of the T-DNA introduced in the event of the present invention. 
         FIG. 4  represents the plasmid used as a base for constructing the plasmid used in the present invention. 
         FIG. 5  represents the resulting plasmid used to obtain the event of interest. 
         FIG. 6  is the graph of qPCR amplification via Taqman® (relative fluorescence×cycle) for the event of interest. 
         FIG. 7  is the qPCR melting curve via SYBR GREEN™ (relative fluorescence×temperature) for the event of interest. The arrows indicate the specific amplification peak of the event of interest at a temperature of 83.5° C. and the non-specific peak presented by some samples, as well as the baseline indications of no amplification for the other negative events and controls. 
         FIG. 8  is the result of comparing means of Cry1Ac protein expression in leaves of the event of the invention during the sugarcane cultivation cycle. Combined analysis for Barrinha, Piracicaba and Valparaiso (SP), Camamu-BA and Quirinópolis-GO. Bars followed by the same letter do not differ by Tukey&#39;s test at the 5% probability level. 
         FIG. 9  is the result of comparing means of Cry1Ac expression in leaves of the event of the invention in sugarcane at 60 and 120 DAP and then 240 and 300 DAP. Combined analysis for Barrinha-SP, Piracicaba-SP, Quirinópolis-GO and Valparaiso-SP. Bars followed by the same letter do not differ by Tukey&#39;s test at the 5% probability level. 
         FIG. 10  is the result of comparing averages of Cry1Ac expression in stems of the event of the invention at 330 DAP. 
         FIG. 11  is the result of comparing means of Pat protein expression in leaves of the event of the invention during the sugarcane cultivation cycle. Combined analysis for Barrinha, Piracicaba and Valparaiso (SP), Camamu (BA) and Quirinópoli (GO) locations. Bars followed by the same letter do not differ by Tukey&#39;s test at the 5% probability level. 
         FIG. 12  is the result of comparing means of Pat protein expression in leaves of the event of the invention in sugarcane at 60 and 120 DAP and then 240 and 300 DAP. Combined analysis for Barrinha-SP, Piracicaba-SP, Quirinópolis-GO and Valparaiso-SP. Bars followed by the same letter do not differ by Tukey&#39;s test at the 5% probability level. 
         FIG. 13  is the result of comparing averages of Pat protein expression in stems of the event of the invention at 330 DAP in the PACE assays. 
         FIG. 14  is the result of the Western blot methodology for identifying the Cry1Ac protein. M: molecular weight marker (kDa). R1 and R2: Event of the invention. CN: parental cultivar. CP1: 50 ng of purified Cry1Ac protein, diluted in total proteins of the parental cultivar. CP2: 5 ng commercial Cry1Ac protein diluted in PBST buffer. CP3: Bt11 corn. CP4: GM sugarcane event expressing Cry1Ac protein. 
         FIG. 15  is the result of the Western blot methodology for identification of Pat. M protein: molecular weight marker (kDa). R1, R2 and R3: biological repeats of the event of the invention. CP1 (positive control 1): 1 ng Bar protein diluted in total protein extracted from parental cultivar. CP2 (positive control 2): 1 ng protein Bar diluted in PBST buffer. 
         FIG. 16  represents natural Infestation Intensity (II %) of  Diatraea saccharalis  in field trials in different locations (Piracicaba (SP), Barrinha (SP), Valparaiso (SP) and Quirinópolis (GO)). CTC91087-6: event of the invention; 9001 TC: Parental cultivar with tissue culture treatment; 9001 WT: Regular Parental cultivar. x-axis represents the percentage of infestation intensity (II %; combined analysis-4 locations). 
         FIG. 17  shows exemplary results of larval size and development after seven days of feeding in the Leaf disc assay. On left (A) are exemplary larvae that were fed with plant material from the insect resistant CTC91087-6 event, and on right (B) are exemplary larvae that were fed with plant material from the conventional (parental—no transgenic) variety CTC9001. 
         FIG. 18  shows results of screenhouse bioassays between CTC91087-6 and its conventional counterpart CTC9001 (parental variety—non transgenic). On left, I) shows exemplary images of visible damage caused by  D. saccharalis  on A: stalk from CTC91087-6 and B: stalk from CTC9001a. The graph in I) shows stalk damage (% Damage) results in the screenhouse. On right, II) shows Infestation Intensity (%) results in the screenhouse. 
         FIG. 19  demonstrates examples of cassettes for generation of event CTC91087-6 through gene editing approach. Cassette A comprises a sugarcane codon optimized Cas9 driven by pZmUbi promoter and T-35s terminator; Cassette B comprises crRNA for Cas9 driven by wheat U3 promoter and Cassette C comprises the HR template comprising 9001BT-T-DNA region with 1 kb homologous arms for site directed integration. 
         FIG. 20  represents an example of a gene editing construction comprising Cas 9 and crRNA Cassettes. 
         FIG. 21  shows an example of a gene editing construction comprising the HR template comprising 9001BT-T-DNA region with 1 kb homologous arms for site directed integration. 
         FIG. 22  represents a gene editing construction comprising the all the cassettes for generation of event CTC91087-6: a codon optimized Cas9 driven by pZmUbi promoter and T-35s terminator; a crRNA for Cas9 driven by wheat U3 promoter and the HR template comprising 9001BT-T-DNA region with 1 kb homologous arms for site directed integration. 
     
    
    
     DETAILED DESCRIPTION OF THE INVENTION 
     First, the term “event” refers to the transgenic plant produced through genetic transformation that stably expresses the desired trait conferred by the introduced transgene. More particularly, in the present case, the term “event” is considered to be the transgenic plant, preferably a sugarcane transgenic plant ( Saccharum  spp.) which, after genetic modification, expresses the characteristic of pest resistance, particularly resistance to the pest  Diatraea saccharalis  (sugarcane borer). In a preferred embodiment, the transgenic sugarcane produced through the genetic transformation is designated CTC91087-6′ and may alternately be referred to as “CTC91087-6 event”. 
     Also, for reference purposes, unless expressly mentioned otherwise, “LB region” means the left border (edge) of T-DNA transfer (5′), and “RB region” means the right border (edge) of T-DNA transfer (3′). 
     Additionally, all biological sequences describe herein, except otherwise explicitly stated, encompass sequences having at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% of identity with the described sequences. 
     Finally, “plant material” means any and all plant tissue or derivatives thereof, such as, but not limited to, seeds, stems, stalks, leaves, straws, bark, roots, cells, molecules of plant origin, among others. In addition, “plant material” may include any product of a plant or derivative thereof, for example, but not limited to, sap, sugar, ethanol, among others. 
     Recombinant DNA technology has enabled the isolation of genes and their stable insertion into a host genome. This technique, also called genetic transformation, can be defined as the controlled introduction of nucleic acids (“DNA” or DNA) into a recipient genome, excluding introduction by fertilization. It is a controlled process where a defined DNA fragment is introduced into the host (or recipient) genome and must be integrated into it. The stable insertion of these molecules into a host genome gives rise to an individual with the genome equal or substantially equal to the recipient (host) of the recombinant molecule, but with a new and particular feature. “Substantially equal” means a genome with more than 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% of identity in relation to the recipient. 
     There are several plant genetic transformation techniques grouped into two main categories: indirect and direct gene transfer. Indirect transfer is when exogenous DNA is inserted into the genome by the action of a biological vector, while direct transfer is based on physical-biochemical processes. 
     Different tissues and/or cells could be used according to the genetic transformation technique and according to the species or genotypes to be transformed. Generally, these tissues or cells include, without limitation, embryogenic callus, callus, protoplasts, embryos, somatic embryos, meristematic tissues, an any other part, tissue or cell of plant with regenerative capacity. 
     Indirect transformation is based on the bacterium-mediated system of the genus  Agrobacterium  and has been the most widely used method for obtaining transgenic plants. Advantages to this method include the ability to transfer relatively long DNA segments without rearrangement while maintaining low copy number integration of the transgenes, thus ensuring greater genotypic stability for the generated events. Several  Agrobacterium  species and strains, plasmids and protocols have been developed and adapted for genetic transformation of several plant species. The advantages of these methods include higher probabilities to single copy events, stable integration, and genetic heritage of the introduced genetic traits, as well as, consistent genic expression through generations and lower rates of gene silencing. 
       Agrobacterium tumefaciens  and  A. rhizogenes  are gram negative soil phytopathogenic bacteria belonging to the Rhizobiaceae family that cause diseases in dicotyledons, known as crown and hairy root galls, respectively. In this plant-pathogen interaction there is a process of natural gene transfer between the  agrobacterium  and the plant cell wherein fragments of bacterial DNA are transferred into the plant cell (T-DNA), integrating with the nuclear genome. In its natural form, the bacterium transfers T-DNA (“transferred DNA”), which is part of the bacterial plasmid called Ti (“tumor-inducing”) and integrates into the genome of infected plant cells. The T-DNA fragment that is transferred to the plant cell is comprised of genes involved in the constitutive biosynthesis of phytohormones (auxins and cytokinins), which alter the normal developmental program of infected tissue and cause tumor formation. In addition, it also contains oncogenes for the synthesis of sugars and amino acids called opines, which serve as carbon and nitrogen sources for bacteria (Oger et al. 1997). Repeated ends of 25 base pairs (bp) at the right and left borders delimit the T-DNA and are essential for its transfer. Phenolic compounds released by injured plant tissues activate specific regions (vir regions), initiating the process of transfer of T-DNA to the plant cell.  Agrobacterium  also has chromosomal (chv) genes that promote binding between bacterial and host cells, allowing the formation of the pore passage of the T-DNA-containing complex (Sheng &amp; Citovsky. 1996). 
     Since the segment to be transferred is defined by its borders, any sequence flanked by the borders can be transferred to a plant by means of agrobacteria, making it possible to manipulate these sequences in order to transfer coding sequences of interest. The replacement or deletion of the coding regions of wild-type T-DNA (oncogenes) allows for the generation of non-oncogenic (disarmed)  Agrobacterium  strains, which can carry the sequences of interest. The modified T-DNA is able to transfer the sequences of interest to plants because the virulence genes (vir region) remain intact. 
     Additionally, the  Agrobacterium  indirect transformation system allows for the transfer of artificial plasmid constructs to plants as long as the constructs contain such T-DNA borders, which enables the flexibility to use molecular tools and materials developed for other bacterial strains. 
     These artificial plasmid constructs have promoters from different origins, as for example, plant promoters, viral promoters, bacterial and or chimeric promoters, besides genes that confer antibiotic resistance, herbicide resistance or tolerance, or enzymatic activity (phosphomannose isomerase (PMI)/mannose (Man)), so these markers can be used for the selection of transformed cells or plants. 
     These constructions also can contain auxiliaries genes which interfere with relevant morphogenesis signaling pathways, enhancing the efficiency of the genetic transformation process and regeneration of vegetal tissues. Included, without limitations, LEAFY COTYLEDON1 (Lotan et al., 1998), Lec1 (Lowe et al., 2002), LEAFY COTYLEDON2 (Stone et al., 2001), WUSCHEL (WUS; Zuo et al., 2002), e BABY BOOM (BBM; Boutilier et al., 2002), among others. 
     In a first aspect of the present invention, foreign or exogenous DNA to be introduced into the plant is cloned into a binary plasmid between the left and right border consensus sequences (T-DNA). The binary plasmid is transferred to an  Agrobacterium  cell, which is subsequently used to infect plant tissue. The T-DNA region of the vector comprising the exogenous DNA is inserted into the plant genome. The marker gene expression cassette and the characteristic gene expression cassette may be present in the same region of T-DNA, in different regions of T-DNA on the same plasmid, or in different regions of T-DNA on different plasmids. In one embodiment of the present invention, the cassettes are present in the same region as the T-DNA. One of skill in the art is familiar with the methods of indirect transformation by  Agrobacterium.    
     Alternatively, direct DNA transfer can be used to directly introduce DNA into a plant cell. One method of direct DNA transfer is to bombard plant cells with a vector comprising DNA for insertion using a particle gun (particle-mediated biolistic transformation). Other methods for transformation of plant cells include protoplast transformation (optionally in the presence of polyethylene glycols); ultrasound treatment of plant tissues, cells, or protoplasts in a medium comprising the polynucleotide or the vector; microinjection of the polynucleotide or vector into plant material; microinjection, vacuum infiltration, sonication, use of silicon carbide, chemical transformation with PEG, electroporation of plant cells and the like. Between the disadvantages of direct transformation are challenges related to regeneration of plant tissue and the low transgene expression. 
     In addition, genetic transformation could be performed by site direct insertion through homologous recombination mediated by nucleases (genome editing). In recent years, genome editing technology based on use of engineered or chimeric nucleases has enabling the generation of genetically modified organisms in a more precise and specific way. The introduction of exogenous or foreign genes occur by homologous recombination through introduction of a Homologous recombination template (HR) having the exogeneous DNA linked to a DNA fragment homologous to the genome of the receptor organism. Between the tools available are the chimeric enzymatic system CRISPR (clustered, regularly interspaced, short palindromic repeats)—Cas, the Zinc finger (ZFN) nucleases and TAL effector nucleases (TALENs). Crispr-Cas systems are enzymatic systems comprising two main components: a endonuclease (Cas) and a guide-RNA (single-guide RNA—sgRNA; a guide to the specific cleavage site of Cas endonuclease). The guide RNA may also comprise of two components: a Crispr RNA (crRNA)—a sequence of 17-20 mer complementary to specific DNA genomic sequences and, optionally, of a tracr RNA. The specific cleavage performed by endonuclease and guide by the sgRNA would be repair by homologous recombination, specifically inserting the exogenous DNA flanked by the homologous sequences to the cleavage site. The introduction of this enzymatic system to the cell could occur by several manners, using plasmids, through direct or indirect transformation, or using carriers like proteins and other chemical agents. The expression of the system components would occur in a transient or stable manner, using the cellular machinery of the receptor organism or being realized in a exogeneous way, in vitro, delivering to the target cell or tissue all the components ready to use (endonucleases+sgRNA, in vitro transcribed and combined before cell delivery). The description presented herein is not exhaustive and should not limit the use of different variations, systems and methods of genome editing on scope of the present invention, known in the State of the Art and even the ones not yet discovered. 
     Following transformation, transgenic plants are regenerated from the transformed plant tissue and the progeny that have exogenous DNA can be selected using an appropriate marker such as kanamycin or ammonium glufosinate resistance. One skilled in the art is familiar with the composition of suitable regeneration media. 
     Alternatively, other selection methods could be applied, without the insertion of any gene marker in the host genome (receptor organism) as described before. 
     In a preferred embodiment, genetic transformation is mediated through a bacterium of the genus  Agrobacterium.    
     In an even more preferred embodiment, genetic transformation is mediated by  Agrobacterium tumefaciens.    
     CTC91087-6 event exhibits a new genotype comprising two expression cassettes. The first expression cassette comprises a promoter suitable for plant expression operably linked to a gene encoding a Cry1Ac insecticide toxin useful in controlling lepidopteran insect pests and a suitable polyadenylation signal. The second expression cassette comprises a promoter suitable for plant expression operably linked to a gene encoding a protein used as a selective marker in obtaining the event of the present invention. 
     Promoters suitable for plant expression may be isolated from plants or from other organisms. Several promoters have been isolated or developed including constitutive promoters, “on and off” promoters, and promoters that are responsive to tissue-specific abiotic stresses, among others. Many of these promoters have intronic sequences described as relevant for proper gene expression. In a preferred aspect of the invention, promoters are constitutive promoters and may be selected from the non-limiting group consisting of CaMV 35S, CoYMV ( Commelina  yellow mottle virus), FMV 35S, Ubiquitin, Actin Rice Promoter (Act-1), Act-2, nopaline synthase promoter (NOS), octopine synthase promoter (OCS), corn alcohol dehydrogenase promoter (Adh-1), PvUbi1, among others. 
     In one embodiment of the invention, the promoter is the maize Ubiquitin (pUBI) gene promoter. In an even more preferred embodiment, the maize Ubiquitin promoter contains an intron in the 5′ sequence of the leader RNA. 
     The promoter region of the present invention (UBI-1) has 1992 base pairs which are subdivided into: promoter fragment (899 bases), first exon of the polyubiquitin-1 gene (83 bases) and first intron (1,010 bases). 
     Additional elements such as enhancer sequences and transporters (transporters) may also be incorporated into the expression cassette for the purpose of enhancing gene expression levels, for example, transcriptional or translation enhancers such as CaMV 35S enhancers, FMV 35S, Nos, supP, among others. 
     Terminator sequences are also contemplated on the expression cassette. Examples of suitable and functional plant polyadenylation signals include those from the  Agrobacterium tumefaciens  nopaline synthase gene (nos), proteinase inhibitor II gene rbcS (pea ribulose-1,5-bisphosphate carboxylase small subunit), Lhcb1 (tobacco chlorophyll a/b-binding proteins), CaMV 35S, octopine synthase, alpha-tubulin gene, among others. 
     In one embodiment of the present invention, the polyadenylation signal is that derived from the  Agrobacterium tumefaciens  nopaline synthase (nos) gene. 
     Preferably, the expression of cry1Ac and bar genes is regulated by the maize ubiquitin gene promoter—UBI-1 (which has an endogenous intron). Both expression cassettes use the  Agrobacterium tumefaciens  nopaline synthase terminator—NOS. 
     The cry1Ac gene encodes a 615 amino acid toxin with an estimated molecular weight of 68 kDa, originating from  Bacillus thuringiensis  serovar kustaki (strain HD73), which confers resistance to  Diatraea saccharalis  (cane borer). The present invention contemplates gene modifications for expression of the active tryptic nucleus of native Cry1Ac protein only. Thus, in a preferred embodiment of the present invention, the polynucleotide encoding the Cry1Ac protein is truncated, encoding the 52 kDa tryptic insecticide nucleus. In a more preferred embodiment, the Cry1Ac protein is SEQ ID NO 34. The present invention also contemplates sequences having at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% of identity with SEQ ID NO: 34. The tryptic nucleus is responsible for the insecticidal activity of the protein, binding to specific proteins of the insect&#39;s gut leading to disruption of the functional and anatomical integrity of this organ. Ingestion of the Cry1Ac protein by the target insect causes altered nutrient absorption, which leads to rapid toxicity and subsequent death of the insect. 
     According to the invention, the polynucleotide encoding the Cry1Ac protein may have optimized (or otherwise altered) codons to improve expression in plant material. Such codon optimization may be used to alter the predicted secondary structure of the RNA transcription product produced in any transformed cell or to destroy the cryptic RNA instability elements present in the unchanged transcription product, thereby enhancing the stability and/or availability of the transcription product in the transformed cell. 
     Preferably, the cry1Ac gene present at the event of the invention corresponds to a truncated synthetic DNA sequence optimized with preferred sugarcane codons. In an even more preferred aspect of the present invention, the cry1Ac gene has the sequence SEQ ID NO: 20. The invention also contemplates sequences having at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% of identity with SEQ ID NO: 20. 
     Several marker genes for plant event selection have already been characterized, including some that confer tolerance to antibiotics and others that confer resistance to herbicides. Examples of marker genes that may be selected for use in the present invention include those that confer resistance or tolerance to hygromycin, kanamycin, gentamicin, glyphosate, ammonium glufosinate or resistance to toxins such as eutypine. Other forms of selection are also available such as hormone-based selection systems, visual selection through expression of fluorescent proteins, mannose isomerase, xylose isomerase, among others. In one embodiment of the present invention, the event selection marker gene is one which confers tolerance to ammonium glufosinate. 
     In a preferred embodiment of the invention, the marker gene used in the second expression cassette is the bialaphos resistance (bar) gene, which encodes the 183 amino acid phosphinothricin acetyltransferase (Pat) enzyme having an estimated molecular weight of 22 kDa. In an even more preferred aspect of the present invention, the bar gene has the sequence SEQ ID NO: 21. Phosphinothricin acetyltransferase confers resistance to the ammonium glufosinate herbicide, which was used in the initial selection process of transformants. The bar gene used as a selective marker to obtain the event of the present invention is derived from  Streptomyces hygroscopicus . The PAT protein can also be expressed from the pat gene of  Streptomyces viridochromogenes.    
     The use of selection marker genes, such as the bar gene, is essential for selecting transformed cells during the process of transformation (HORSCH et al., 1985). The purpose of insertion of the bar gene in the event of the present invention was therefore the selection of cells transformed with the cry1Ac gene. In particular, this gene was chosen because the ammonium glufosinate herbicide is not used for weed control in sugarcane cultivation and cannot be used in the handling of the event of the invention under field conditions. 
     In addition to the expression cassettes described, additional expression cassettes may also be used in event CTC91087-6. 
     The first and second expression cassettes comprised in event CTC91087-6 may be introduced into the plant on the same or on different plasmids. If the first and second expression cassettes are located on the same plasmid and are introduced into the plant by an  Agrobacterium -mediated transformation method, they may be present within the same or different regions of T-DNA. In one embodiment of the present invention, the first and second expression cassettes are present in the same region as the T-DNA. 
     More particularly, the event of the present invention was obtained by  Agrobacterium  tumefasciens-mediated transformation with a genetic construct comprising a DNA fragment (T-DNA) containing the cry1Ac and bar gene expression cassettes. Preferably, the genetic construct of the present invention comprises the nucleotide of sequence SEQ ID NO:1. 
     The event of the present invention was obtained by  Agrobacterium  tumefasciens-mediated transformation containing the T-DNA fragment as defined above (SEQ ID NO:1). 
     This T-DNA fragment was inserted into a binary plasmid that contains in its host spectrum the bacteria  Escherichia coli  and  Agrobacterium tumefaciens . Specific genetic elements and the origins of the components of the original binary plasmid of the present invention are shown in  FIG. 4 . The binary plasmid comprising the construct of the present invention is depicted in  FIG. 5 . 
     In a preferred embodiment, the genetic construct of the present invention comprises the sequence of SEQ ID NO:14. 
     Said construct is transferred to an  Agrobacterium tumefaciens  (vector) strain by techniques known to one of ordinary skill in the art, such as electroporation or thermal shock, among others. 
     In an even more preferred embodiment, the vector is an  Agrobacterium tumefaciens  strain EHA105. 
     A method for producing the event of interest is further described. In a preferred embodiment, the said method comprising the steps of:
         a) introducing a genetic construct into an  Agrobacterium  strain;   b) obtaining embryogenic callus from immature leaf rolls or top stalks of sugarcane ( Saccharum  spp.);   c) co-cultivating embryogenic callus with a culture of  Agrobacterium;      d) selecting transformed cells containing the functional fragment in culture medium containing ammonium glufosinate; and   e) regenerating transformed sugarcane plants.       

     In one embodiment, the step a) of the method of producing a genetically modified sugarcane ( Saccharum  spp.) plant of event CTC91087-6 comprises introducing a genetic construct comprising SEQ ID NO: 20 and SEQ ID NO: 21 into an  Agrobacterium  strain. Additionally, step e) of said method comprises regenerating transformed sugarcane plants, wherein the genetically modified sugarcane plants comprise SEQ ID NO: 20 and SEQ ID NO: 21. The invention also contemplates, a plant part, plant cell, plant tissue, or seed of the genetically modified sugarcane plants produced by the method described herein. 
     Those skilled in the art are familiar with the composition of suitable culture media for the generation of embryogenic callus (stage b), as well as the means of the co-cultivation stages (stage c: co-cultivation+rest), selection (stage d), and regeneration (stage e; regeneration+elongation). Preferably, the culture media used are based on compositions comprising ingredients such as MS salts (Murashige and Skoog, 1962), sucrose, and vitamins B5. Optionally, the following can also be added: amino acids selected from the group comprising proline and asparagine; casein hydrolysate; citric acid; mannitol; copper sulfate; glycine; gelling agent; auxins; antibiotics; acetosyringone; and selection agents. The use of auxins is especially important in embryogenic callus generation, co-cultivation and selection, as well as ammonium glufosinate in the selection medium. 
     The “co-cultivation” step refers to the incubation of plant tissue that has been infected or contacted with  Agrobacterium  to allow the transfer of  Agrobacterium  T-DNA to plant cells. This stage corresponds to the period from the moment immediately after inoculation (contact of  Agrobacterium  with plant tissue) until the moment the bacterium is removed or inactivated. 
     Inoculated tissue may be co-cultured for about 1 to 30 days, preferably from 1 to 20 days, or more preferably from 1 to 10 days. 
     During the co-cultivation step, the temperature may be any suitable temperature known in the art for the target plant. Illustratively, for sugarcane, the temperature may range from about 15° C. to about 30° C. and from about 16° C. to about 29° C. In some embodiments, the co-cultivation step occurs in the absence of light. 
     Following co-cultivation with  Agrobacterium , the medium is removed and the cells are transferred to a culture medium lacking  Agrobacterium . The cells are then incubated in the dark at a temperature between about 20° C. and about 26° C. for a period of 1 to 20 days. 
     The method provided herein further includes selecting cells comprising at least one copy of the genetic sequence of interest. “Select” as used herein means the situation in which a selective agent is used for transformants, wherein said selective agent will allow preferential growth of plant cells containing at least one copy of the marker gene positioned within the T-DNA. Whereas, those cells that were not transformed will not contain the marker gene that permits survival in the selective agent. As indicated above, any suitable selection marker may be used. Preferably, the selection marker gene used is the bar gene, which encodes an enzyme that confers resistance to ammonium glufosinate. 
     In some embodiments, an agent that inhibits  Agrobacterium  growth is also added. 
     Selection may occur under light or dark conditions, depending on the plant species being transformed and on the genotype, for example. In some cases, embryogenic callus or other tissues undergoing transformation may be sub-cultured at regular or irregular intervals in the same medium. In the case of callus transformation, individual calluses can be kept separate to ensure that only one plant is regenerated by each callus (thus ensuring that all regenerated plants are derived from independent transformation events). In a preferred embodiment, the selection step occurs in the dark using ammonium glufosinate as a selection agent for about 1 to 10 weeks. More preferably the selection step occurs for about 2 to 5 weeks. 
     After the selection period, plant tissue that has continued to grow in the presence of the selection agent, and has therefore been genetically modified, can be manipulated and regenerated by placing it in suitable culture media and growth conditions. The transgenic plants thus obtained can be tested for the presence of the DNA of interest. For the purpose of this invention, the term “regenerate” refers to the formation of a plant comprising both an aerial part and roots. Regenerated plants can be planted on suitable substrate (such as soil) and transferred to the greenhouse. As used herein, “genetically modified” or “transgenic” or “stably transformed” means a plant cell, plant part, plant tissue, or plant that comprises a DNA sequence of interest that is introduced into its genome by transformation. 
     In one embodiment, the bacterium is of the genus  Agrobacterium.    
     In a more preferred embodiment, the bacterium is  Agrobacterium tumefaciens.    
     In an even more preferred embodiment, the bacterium is an  Agrobacterium tumefaciens  strain EHA105. 
     The present invention also relates to the characterization of the selected event (CTC91087-6) and methods of detecting plant material derived therefrom. Analytical methods for detection and characterization of transgenic plants include indirect methods (protein-based detection methods) or direct methods (DNA-based detection methods). 
     The definition of the T-DNA stable integration site in the host cell genome and the characterization of its flanking sequences is necessary for the development and validation of methodologies for the unambiguous identification and characterization of the event. 
     To identify the flanking regions at the ends of the T-DNA insert in event CTC91087-6, several DNA amplification and sequencing experiments were performed. Inverse PCR (iPCR) assays were performed at both ends of the T-DNA to isolate and clone the flanking regions of the insert. Subsequently, the fragments obtained and isolated were sequenced using the Sanger method to validate the results obtained by iPCR. The genetic insertion map present in event CTC91087-6 resulting from the data generated by these experiments is shown in  FIG. 3  and SEQ ID NO: 2. The flanking sequences of event CTC91087-6 are shown in SEQ ID NO: 23 and SEQ ID NO: 24. 
     According to one aspect of the invention, a polynucleotide comprising at least 14 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 18 is provided. In one embodiment, a polynucleotide comprising at least 15 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 18 is provided. In one embodiment, a polynucleotide comprising at least 16 contiguous nucleotides of the 26 nucleotides of SEQ ID NO: 18 is provided. In one embodiment, said polynucleotide comprises at least 17 contiguous nucleotides of the 26 nucleotides of SEQ ID NO: 18. In one embodiment, said polynucleotide comprises at least 18 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 18. In one embodiment, said polynucleotide comprises at least 19 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 18. In one embodiment, said polynucleotide comprises at least 20 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 18. In one embodiment, said polynucleotide comprises at least 21 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 18. In one embodiment, said polynucleotide comprises at least 22 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 18. In one embodiment, said polynucleotide comprises at least 23 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 18. In one embodiment, said polynucleotide comprises at least 24 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 18. In one embodiment, said polynucleotide comprises at least 25 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 18. In one embodiment, said polynucleotide comprises SEQ ID NO: 18. In one further aspect of the invention, said polynucleotide comprises SEQ ID NO: 13. 
     According to one aspect of the invention, a polynucleotide comprising at least 14 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO 19 is provided. In one embodiment, a polynucleotide comprising at least 15 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO 19 is provided. According to one aspect of the invention, a polynucleotide comprising at least 16 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO 19 is provided. In one embodiment, a polynucleotide comprising at least 17 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 19 is provided. In one embodiment, a polynucleotide comprising at least 18 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 19 is provided. In one embodiment, a polynucleotide comprising at least 19 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 19 is provided. In one embodiment, a polynucleotide comprising at least 20 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 19 is provided. In one embodiment, a polynucleotide comprising at least 21 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 19 is provided. In one embodiment, a polynucleotide comprising at least 22 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 19 is provided. In one embodiment, a polynucleotide comprising at least 23 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 19 is provided. In one embodiment, a polynucleotide comprising at least 24 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 19 is provided. According to one aspect of the invention, a polynucleotide comprising at least 25 contiguous nucleotides of the 26 nucleotides of SEQ ID NO: 19 is provided. In one embodiment, a polynucleotide comprising SEQ ID NO: 19 is provided. In one aspect of the invention, a polynucleotide comprising SEQ ID NO: 12 is provided. 
     In a further aspect of the present invention a polynucleotide comprising the sequence of SEQ ID NO: 5 is provided. In still another aspect of the invention, a polynucleotide comprising the sequence SEQ ID NO: 22 is provided. 
     According to one aspect of the invention, there is provided a plant comprising at least 14 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 18. In one embodiment, a plant comprising at least 15 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 18 is provided. According to one aspect of the invention, there is provided a plant comprising at least 16 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 18. In one embodiment, a plant comprising at least 17 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 18 is provided. In one embodiment, a plant comprising at least 18 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 18 is provided. In one embodiment, a plant comprising at least 19 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 18 is provided. In one embodiment, a plant comprising at least 20 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 18 is provided. In one embodiment, a plant comprising at least 21 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 18 is provided. In one embodiment, a plant comprising at least 22 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 18 is provided. In one embodiment, a plant comprising at least 23 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 18 is provided. In one embodiment, a plant comprising at least 24 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 18 is provided. In one embodiment, a plant comprising at least 25 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 18 is provided. In one embodiment, a plant comprising SEQ ID NO: 18 is provided. In an additional embodiment, a plant comprising SEQ ID NO: 13 is provided. 
     According to one aspect of the invention, there is provided a plant comprising at least 14 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 19. In one embodiment, a plant comprising at least 15 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 19 is provided. In one embodiment, a plant comprising at least 16 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 19 is provided. In one embodiment, a plant comprising at least 17 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 19 is provided. In one embodiment, a plant comprising at least 18 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 19. In one embodiment, a plant comprising at least 19 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 19 is provided. In one embodiment, a plant comprising at least 20 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 19 is provided. In one embodiment, a plant comprising at least 21 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 19 is provided. In one embodiment, a plant comprising at least 22 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 19 is provided. In one embodiment, a plant comprising at least 23 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 19 is provided. In one embodiment, a plant comprising at least 24 contiguous nucleotides of the 26 nucleotides of sequence SEQ ID NO: 19 is provided. In one embodiment, a plant comprising at least 24 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 19 is provided. In one embodiment, a plant comprising at least 25 contiguous nucleotides of the 26 nucleotide sequence of SEQ ID NO: 19 is provided. In one embodiment, a plant comprising SEQ ID NO: 19 is provided. In an additional embodiment, a plant comprising SEQ ID NO: 12 is provided. 
     In one embodiment of the present invention, said plant is a genetically modified sugarcane ( Saccharum  spp.) plant. Additionally, said plant is insect resistant and comprises the sequence SEQ ID NO: 5. Still in a further aspect, the insect resistant plant of the present invention comprises SEQ ID NO: 22. In a further embodiment, said plant is an insect-resistant sugarcane plant of event CTC91087-6 or a plant derived therefrom. 
     In one aspect of the invention, event CTC91087-6 is a sugarcane ( Saccharum  spp.) plant comprising SEQ ID NO: 5. In a further aspect, event CTC91087-6 comprises SEQ ID NO: 22. 
     In other embodiment a specific method for detection and identification of CTC91087-6 event is provided. 
     According to the present invention, there is provided a method of detecting plant material derived from genetically modified sugarcane of event CTC91087-6 comprising the steps of:
         a) obtaining a plant material sample for analysis;   b) extracting DNA from the sample;   c) providing primer pairs comprising at least a forward and a reverse primer;   d) amplifying a region between the primer pairs; and   e) detecting the presence of a product from amplification.       

     In one embodiment, the primer pairs in step c) are designed to bind to a polynucleotide comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 22 and SEQ ID NO: 29, wherein at least one pair of primers comprises contiguous nucleotides sequences selected from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31. 
     In one embodiment, the primer pairs above (step c) are designed to bind to a polynucleotide comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 22 and SEQ ID NO: 29, wherein at least one primer pair comprises at least 3 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31. In one embodiment, the primer pairs are designed to bind to a polynucleotide comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 22 and SEQ ID NO: 29, wherein at least one primer pair comprises at least 7 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31. In addition, the primer pairs are designed to bind to a polynucleotide comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 22 and SEQ ID NO: 29, wherein at least one primer pair comprises at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31. 
     Additionally, primer pairs according to the detection method described are designed to bind to a polynucleotide comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 22 and SEQ ID NO: 29, where at least one primer pair consists of a first primer comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31 and a second primer comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 2 and SEQ ID NO: 36. 
     In one embodiment, the primer pairs according to the detection method described are designed to bind to a polynucleotide comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 22 and SEQ ID NO: 29, wherein at least one primer pair consists of a first primer comprising at least 3 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31 and a second primer comprising at least 3 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 2 and SEQ ID NO: 36. In an additional embodiment, primer pairs are designed to bind to a polynucleotide comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 22 and SEQ ID NO: 29, wherein at least one primer pair consists of a first primer comprising at least 7 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31 and a second primer comprising at least 7 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 2 and SEQ ID NO: 36. In addition, primer pairs are designed to bind to a polynucleotide comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 22 and SEQ ID NO: 29, wherein at least one primer pair consists of a first primer comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31 and a second primer comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 2 and SEQ ID NO: 36. 
     In one embodiment, primer pairs according to the detection method described are designed to bind to a polynucleotide comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 5 and SEQ ID NO: 37, wherein at least one pair of primers comprises contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 and SEQ ID NO: 39. In one embodiment, primer pairs according to the detection method described are designed to bind to a polynucleotide comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 5 and SEQ ID NO: 37, wherein at least one primer pair comprises at least 3 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 and SEQ ID NO: 39. In one embodiment, primer pairs are designed to bind to a polynucleotide comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 5 and SEQ ID NO: 37, wherein at least one primer pair comprises at least 7 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 and SEQ ID NO: 39. In addition, primer pairs are designed to bind to a polynucleotide comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 5 and SEQ ID NO: 37, wherein at least one primer pair comprises at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 and SEQ ID NO: 39. 
     In one embodiment, primer pairs according to the detection method described are designed to bind to a polynucleotide comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 5 and SEQ ID NO: 37, wherein at least one primer pair consists of a first primer comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 and SEQ ID NO: 39 and a second primer comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 2 and SEQ ID NO: 36. In one embodiment, primer pairs, according to the detection method described, are designed to bind to a polynucleotide comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 5 and SEQ ID NO: 37, wherein at least one primer pair consists of a first primer comprising at least 3 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 and SEQ ID NO: 39 and a second primer comprising at least 3 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 2 and SEQ ID NO: 36. In one embodiment, primer pairs are designed to bind to a polynucleotide comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 5, SEQ ID NO: 36 and SEQ ID NO: 37, wherein at least one primer pair consists of a first primer comprising at least 7 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4 SEQ ID NO: 38 and SEQ ID NO: 39 and a second primer comprising at least 7 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 2 and SEQ ID NO 36. Additionally, primer pairs are designed to bind to a polynucleotide comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 5 and SEQ ID NO: 37, wherein at least one primer pair consists of a first primer comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 and SEQ ID NO: 39 and a second primer comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 2 and SEQ ID NO: 36. 
     It is well known, especially to those skilled in the art, that the DNA molecule (or DNA) is made up of two strands (of nucleotides) that are held together by hydrogen bridges between the nucleotide bases. Pairing occurs according to the complementarity of the bases, following the general rule of: Adenine with Thymine and Cytosine with Guanine. Thus, although representation of nucleotide sequences is performed for only one of the strands, their complementary strand or complementary sequence is included within the scope of this invention and is considered for the definition of primers and probes described herein. 
     Methods for obtaining samples for DNA extraction are widely known to one of ordinary skill in the art and include the collection of any plant material derived from the CTC91087-6 transgenic event such as stems, roots, and leaves. Preferably, the samples are obtained from intact leaves. Plant DNA extraction methods include, without limitation, those based on the use of CTAB detergent (Alianabi et al., 1999), (optionally) followed by further sample purification with cesium chloride or ammonium acetate, as well as other commercially available methods. 
     Primer pairs suitable for use in this detection method may be designed using parameters well known to those skilled in the art of molecular biology now that SEQs ID Nos: 2, 3, 4, 5, 22, 23, 24, 29, 30, 31, 36, 37, 38 and 39 have become available. For example, one or both primers of the pair may be designed to be construct-specific, trait gene-specific, promoter-specific, sequence-specific to the junction between inserted DNA and genomic DNA, and/or flanking sequence-specific. 
     There are many amplification methods that can be used in accordance with this aspect of the invention. One of the most common amplification techniques known to those skilled in the art, is the polymerase chain reaction (PCR). The amplification product of a PCR reaction can be visualized by staining the nucleotide chain with a fluorescent tag such as ethidium bromide and then exciting it with UV light (typically after size separation using agarose gel electrophoresis). 
     One embodiment of the present invention employs variations of the PCR principle such as quantitative real-time PCR, nested PCR, inverse PCR (iPCR), digital PCR, Long PCR, Touchdown PCR, Hot Start PCR, Multiplex PCR, among others. The amplification product can also be detected by different methodologies which are contemplated in the present invention, such as the SYBR Green™ system which emits fluorescence when this reagent binds to double stranded DNA and the Taqman® system where detection is based on the interaction of fluorescent probes. The Taqman® methodology uses a probe that is complementary to the intended PCR product segment located between the reaction primers. During the hybridization stage of the PCR cycle the probe is bound to the target DNA, and during Taq polymerase extension, through its 5′-exonuclease activity, it removes the probe, releasing the fluorochrome and emitting fluorescence. Additional embodiments of this aspect of the present invention include, but are not limited to: loop-mediated isothermal amplification (LAMP), capillary gel electrophoresis (CGE), microarray technology Luminex, “DNA walking” and Next Generation Sequencing (NGS), Sanger method, Illumina, among others. 
     The present invention describes a specific detection methodology based on the quantitative real-time PCR (qPCR) technique known as “Plus-Minus” or “Presence—Absence,” presenting two variations of the methodology: SYBR GREEN™ and Taqman® technology. 
     In one embodiment of the present invention, primer pairs are provided wherein the forward primer consists of SEQ ID NO: 6 and the reverse primer consists of SEQ ID NO: 7 and/or the forward primer is SEQ ID. NO: 8 and the reverse primer is SEQ ID NO: 9. 
     In an additional embodiment, the primer pairs used in step c) of the method of detecting plant material from genetically modified sugarcane of event CTC91087-6 comprise forward primer consists of SEQ ID NO: 6 and the reverse primer consists of SEQ ID NO: 7 and/or the forward primer is SEQ ID NO: 8 and the reverse primer is SEQ ID NO: 9. In addition, the amplicon (product from amplification) produced by the primers of SEQ ID NO: 6 and SEQ ID NO: 7 is viewed through a labeled probe of SEQ ID NO: 10. Alternatively, the amplicon produced by the primers of SEQ ID NO: 8 and SEQ ID NO: 9 is visualized through a labeled probe of SEQ ID NO 11. Thus, it is an aspect of the present invention that detection of the of the product from amplication obtained by the use of primers SEQ ID NO: 6 and SEQ ID NO: 7 and/or SEQ ID NO: 8 and SEQ ID NO: 9 is performed through hybridization of a probe comprising SEQ ID NO: 10 or SEQ ID NO: 11. 
     In one embodiment of the present invention, the region amplified by said method (the amplicon or product from amplification) is between 80 and 1000 base pairs in length. In an additional embodiment, the amplicon is between 100 and 300 base pairs in length. In one preferred embodiment, the amplicon obtained using the primers SEQ ID NO: 6 and SEQ ID NO: 7 is 117 base pairs in length, as defined by SEQ ID NO: 12. In another preferred embodiment, the amplicon obtained through the use of primers SEQ ID NO: 8 and SEQ ID NO: 9 is 149 base pairs in length, as defined by SEQ ID NO: 13. 
       FIGS. 6  (event-specific detection reaction of the invention via Taqman®) and  7  (SYBR GREEN™ assay) represent the validation of both Methods. 
     Primers and probes described in the present invention may be used in combination to detect the CTC91087-6 event. Thus, a further embodiment of the present invention involves the use of multiplex PCR to identify plant material from the CTC91087-6 event. 
     Alternative primers and probes for the detection and characterization of the CTC91087-6 event are included in the invention. These and other variations may be used with but are not limited to any of the direct detection methods described above. 
     Additionally, the CTC91087-6 event can be detected from plant material by hybridizing DNA samples to the probes. Specifically, the present invention describes a method of detecting material from the genetically modified sugarcane event CTC91087-6 which comprises the steps of:
         a) obtaining a plant material sample for analysis;   b) DNA or RNA extraction from the sample;   c) providing a probe designed to bind to a polynucleotide comprising 14 or more contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33, when the polynucleotide is single stranded;   d) hybridizing said probe with the sample, and   e) detecting the actual hybridization of the probe.       

     According to one aspect of the invention, a probe designed to bind to a polynucleotide comprising at least 15 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33 is provided. In one embodiment, a probe designed to bind to a polynucleotide comprising at least 16 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33 is provided. According to one aspect of the invention, a probe designed to bind to a polynucleotide comprising at least 17 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33 is provided. In one embodiment, said polynucleotide comprises at least 18 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33. In one embodiment, said polynucleotide comprises at least 19 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33. In one embodiment, said polynucleotide comprises at least 19 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33. In one embodiment, said polynucleotide comprises at least 20 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33. In one embodiment, said polynucleotide comprises at least 21 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33. In one embodiment, said polynucleotide comprises at least 22 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33. In one embodiment, said polynucleotide comprises at least 23 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33. In one embodiment, said polynucleotide comprises at least 24 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33. According to one aspect of the invention, a polynucleotide comprising at least 25 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33 is provided. According to one aspect of the invention, a polynucleotide comprising at least 26 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33 is provided. 
     The probe may be, for example, a PCR product or a restriction digest fragment. In a further embodiment, the probe as described herein may be labeled with a fluorescent, radioactive, enzymatic, or other label suitable to enable hybridization to be detected. The person skilled in the art will now know how to design suitable probes given the advantage of the present disclosure. 
     In an additional embodiment, a probe hybridization method is provided to the sample under stringent conditions (high specificity). Stringent hybridization conditions are well known to those skilled in the art. Examples of stringent conditions include: hybridization at a temperature of approximately 65° C. in a solution containing 6×SSC, 0.01% SDS and 0.25% skimmed milk powder followed by washing at the same temperature in a solution containing 0.2×SSC and 0.1% SDS. 
     Suitable techniques for detecting plant material derived from event CTC91087-6 based on the hybridization principle include, but are not limited to, Southern Blots and in situ hybridization. One of skill in the art is familiar with such techniques. 
     Typically, these techniques involve incubating a probe with a sample, washing to remove the unbound probe, and detecting whether the probe has hybridized. Said detection method is dependent upon the type of label attached to the probe. For example, a radio-labelled probe can be detected by exposure to and development of X-ray film. Alternatively, an enzymatically labeled probe may be detected by converting a substrate to effect a color change. 
     Additionally, another aspect of the invention contemplates a method for detecting plant material derived from event CTC91087-6, which comprises: obtaining a sample for analysis; providing an antibody designed to bind to a Cry or Pat protein contained within a plant comprising at least 14 contiguous nucleotides of SEQ ID NO: 18 and/or SEQ ID NO: 19; incubating said antibody with the sample; and detecting whether the antibody bound. In one embodiment of the present invention, said Cry protein is encoded by nucleotide sequence SEQ ID NO: 20 and said Pat protein is encoded by nucleotide sequence SEQ ID NO: 21. In an additional embodiment, said Cry protein comprises SEQ ID NO: 34 and said Pat protein comprises SEQ ID NO: 35. 
     Suitable methods for detecting plant material derived from the CTC91087-6 event based on said antibody binding include (but are not limited to): western blots, ELISA (Enzyme-Linked ImmunoSorbent Assays), and mass spectrometry (e.g. surface-enhanced laser desorption/ionization (SELDI)). One of skill in the art is familiar with these immunological techniques. Typical steps include incubating a sample with an antibody that binds to the Cry or Pat protein, washing for removal of unbound antibody, and detecting whether the antibody has bound. Many such detection methods are based on enzymatic reactions: for example, the antibody may be linked with an enzyme such as peroxidase and upon application of a suitable substrate, a color change is detected. Such antibodies may be monoclonal or polyclonal. 
     Another aspect the invention contemplates a method for detecting plant material derived from event CTC91087-6, which comprises: obtaining a sample for analysis; providing a protein extract from the sample; providing test strips designed to detect the presence of a Cry or Pat protein in a plant comprising at least 14 contiguous nucleotides of SEQ ID NO: 18 and/or SEQ ID NO: 19; incubating the test strips with the sample; and detecting. In one embodiment of the present invention, said Cry protein is encoded by nucleotide sequence SEQ ID NO: 20 and the Pat protein is encoded by nucleotide sequence SEQ ID NO: 21. In an additional embodiment, said Cry protein comprises SEQ ID NO: 34 and said Pat protein comprises SEQ ID NO: 35. 
     In one embodiment of the invention there is provided a method for detecting plant material derived from the CTC91087-6 event, said method comprising: obtaining a sample derived from the CTC91087-6 event and a sample from a non-transgenic sugarcane variety for analysis (control); subjecting one or more insects of the species  Diatraea saccharalis  (susceptible to Cry1Ac) to the samples; detecting an insecticidal effect on the insects. In this aspect of the invention, “insecticide” refers to any inhibitory effect on the insect (including but not limited to): reduced feeding, retarded growth, reduced fecundity, paralysis, and death. 
     The method of detecting plant material from event CTC91087-6 includes, but is not limited to, biological leaf feeding assays where a leaf or other suitable part of the plant of event CTC91087-6, or any plant material derived from event CTC91087-6, is infested with one or more insect pests. Measurement of said detection can include: assessing leaf or plant damage after adjusted time periods, assessing mortality or assessing other insecticidal effects. Such biological assays may be performed in the field or greenhouses and may entail either natural or artificial insect infestation. 
     In another aspect of the invention, a kit for detecting in a plant sample the presence of event CTC91087-6 is provided, said kit comprising: a means for detecting the presence of a polynucleotide comprising at least 14 contiguous nucleotides of the sequence of SEQ ID NO: 18 and/or SEQ ID NO: 19 and/or a pesticidal crystal protein (Cry). In one embodiment of the present invention, said kit may comprise DNA amplification detection technology such as PCR, qPCR, or Taqman®. In a further embodiment of the present invention, said kit may comprise probe hybridization detection technology such as Southern Blots or in situ hybridization. In one aspect, the means to detect material from transgenic sugarcane comprising a Cry1Ac protein (event CTC91087-6) comprises primer pairs designed to bind to a polynucleotide comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 22 and SEQ ID NO: 29, wherein at least one pair of primers comprises contiguous nucleotides sequences selected from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31. Additionally, the means comprise primer pairs, wherein the forward primer comprises SEQ ID NO: 6 and the reverse primer comprises SEQ ID NO: 7, or the forward primer comprises SEQ ID NO: 8 and the reverse primer comprises SEQ ID NO: 9. In a further embodiment, the means to detect material from transgenic sugarcane comprising a Cry1Ac protein (event CTC91087-6) comprises a probe comprising SEQ ID NO: 10 or SEQ ID NO: 11. In another embodiment of the present invention, said kit may comprise antibody binding detection technology such as western blots, ELISAs, mass spectrometry (SELDI) or test strips. In a further embodiment of the present invention, said kit may comprise detection technology by biological insect testing such as leaf feeding biological assays or biological mortality assays. In a further embodiment of the present invention, said kit may comprise any combination of the detection technologies mentioned above. 
     The transgenic event as described in the present invention affect insects of one or more species of the group comprising insects of the order  Lepidoptera . As a result, a reduced number of insecticidal sprays is required during cultivation of said plant compared with a non-transgenic sugarcane plant of the same variety. 
     The present invention is not itself bound to event CTC91087-6; rather, it is further extended to include any plant material derived therefrom, including seed, provided they contain at least one of the polynucleotides sequences of the present invention. In one embodiment, the present invention comprises a plant part, plant cell, plant tissue, or seed from the genetically modified sugarcane ( Saccharum  spp.) plant, wherein said plant part, plant cell, plant tissue, or seed comprises SEQ ID NO: 18 or SEQ ID NO: 19. In other embodiment, the invention contemplates plant part, plant cell, plant tissue, or seed comprising SEQ ID NO: 12 or SEQ ID NO: 13. Additionally, the invention includes a plant part, plant cell, plant tissue, or seed comprising SEQ ID NO: 5 or SEQ ID NO: 22. The present invention also includes, but is not limited to, plants that are derived from crossbred lineages with the CTC91087-6 event or a derivative thereof by conventional or other crossbreeding methods; thus, one embodiment of the present invention relates to the use of a plant, plant cell, plant part, or seed from the genetically modified sugarcane ( Saccharum  spp.) plant as described herein, which is used for regenerating a plant, planting, cultivating a field of plants, or producing a plant product. The present invention also contemplates a tissue culture of a genetically modified sugarcane ( Saccharum  spp.) plant comprising SEQ ID NO: 18 or SEQ ID NO: 19. In other embodiment, the invention includes a tissue culture of a genetically modified sugarcane ( Saccharum  spp.) plant comprising SEQ ID NO: 12 or SEQ ID NO: 13. Also contemplate in the present invention is a tissue culture of a genetically modified sugarcane ( Saccharum  spp.) plant comprising SEQ ID NO: 5 or SEQ ID NO: 22. Additionally, a genetic modified sugarcane ( Saccharum  spp.) plant regenerated from the tissue culture describe above is also included in the present invention, wherein the regenerate plant comprises SEQ ID NO: 18 or SEQ ID NO: 19. Examples of plant cells and plant parts include but are not limited to: suspension cells, callus, somatic embryos, meristematic tissue, top stalks, stalks, leaf, leaf discs, tiller, shoots. Another aspect contemplates a method for producing an insect-resistant sugarcane ( Saccharum  spp.) plant, comprising crossing a first sugarcane plant with a second sugar cane plant, wherein the second sugar cane plant is a plant comprising event CTC91087-6, and producing offspring sugarcane plants therefrom. The plant comprising event CTC91087-6 is a genetically modified sugarcane ( Saccharum  spp.) plant comprising SEQ ID NO: 18 or SEQ ID NO: 19. The present invention also contemplates a sugarcane ( Saccharum  spp.) plant and plant parts, plant cells, plant tissues, or seeds therefrom produced by the method for producing an insect-resistant sugarcane described above. 
     In a further embodiment, the present invention provides a commodity product, produced from a sugarcane plant comprising event CTC91087-6. Thus, the invention includes a commodity product, produced from a genetically modified sugarcane ( Saccharum  spp.) plant comprising SEQ ID NO: 18 or SEQ ID NO: 19. In one embodiment, the invention contemplates a commodity product, produced from a genetically modified sugarcane ( Saccharum  spp.) plant comprising SEQ ID NO: 12 or SEQ ID NO: 13. Additionally, the invention includes a commodity product, produced from a genetically modified sugarcane ( Saccharum  spp.) plant comprising SEQ ID NO: 5 or SEQ ID NO: 22. Examples of commodity products include but are not limited to: bagasse, sugarcane juice, syrup, first generation ethanol (produced from sugarcane juice), second generation ethanol (cellulosic ethanol; produced from biomass), biomass, sugar, raw sugar, refined sugar, molasses, vinasse, and fiber. 
     The present invention further provides a plant material from CTC91087-6 event comprising additional polynucleotide sequences, modified or smaller than CTC91087-6, or exhibit other phenotypic characteristics. For example, the plant material CTC91087-6 event could be transformed to produce a new event comprising additional characteristics, such as, a second insect resistance gene. This process is known as gene stacking. Such second insect resistance gene codes, for example, insecticidal lectins, insecticidal protease inhibitors and other insecticidal proteins derived from  Bacillus thuringiensis.    
     The present invention further provides an insect control method comprising providing plant material derived from the CTC91087-6 event at a location where said insects feed. The invention further provides an insect control method comprising providing the CTC91087-6 derived plant material at the site where said insects feed and applying other agrochemical reagents to said plant material (e.g. herbicides, fungicides, and the like). 
     In other embodiment, the invention describes, a method of making a genetically modified sugarcane ( Saccharum  spp.) plant of event CTC91087-6, comprising introducing a genetic modification to a sugarcane ( Saccharum  spp.) plant comprising SEQ ID NO: 5 or SEQ ID NO: 22 to produce a genetically modified sugarcane ( Saccharum  spp.) plant of event CTC91087-6, wherein the genetically modified sugarcane ( Saccharum  spp.) plant has improved insect resistance as compared to a sugarcane ( Saccharum  spp.) plant without the genetic modification. In one additional embodiment, the invention provides a method of cultivating a genetically modified sugarcane ( Saccharum  spp.) plant of event CTC91087-6, comprising growing a genetically modified sugarcane ( Saccharum  spp.) plant of event CTC91087-6 comprising SEQ ID NO: 5 or SEQ ID NO: 22 under conditions comprising insect infestation, wherein the genetically modified sugarcane ( Saccharum  spp.) plant has an increase in insect resistance as compared to a sugarcane ( Saccharum  spp.) plant without the genetic modification grown under the same conditions. The invention also provides, a genetically modified sugarcane ( Saccharum  spp.) plant of event CTC91087-6 comprising SEQ ID NO: 5 or SEQ ID NO: 22. 
     Description of Transgenic Sugarcane ‘CTC91087-6’ 
     Transgenic hybrid sugarcane ‘CTC91087-6’ plants are genetically and phenotypically substantially equal to the recipient (host) of the recombinant molecule, the parental plant variety ‘CTC9001’, a commercial Brazilian sugarcane variety (Plant variety protection registry number (SNPC): 20130226), but with a new and particular feature (Cry1Ac expression), which guarantees the insect resistance to sugarcane borer  D. saccharalis  ( Lepidoptera ). As its parental variety ‘CTC9001’, ‘CTC91087-6’ is a modern sugarcane hybrid that holds several desirable agronomic characteristics such as adaptability to mechanical harvest system adopted by the majority of the Brazilian sugarcane growers, genetic potential for high ratoon cane sprouting vigor, high cane yield, excellent ratooning, low fiber and high sucrose content. ‘CTC91087-6’ demonstrates early maturity and, besides insect resistance, the event is also resistant to leaf scald, smut, brown and orange rust diseases. 
     Briefly, ‘CTC91087-6’ plants are characterized by purple stalks with greenish hues when exposed to sunlight and by yellowish green stalks under the straws. ‘CTC91087-6’ plants exhibit medium size curved-shaped internodes and narrow width greenish yellow growth rings. Internodes were smooth with few, if any, corky patches or cracks, without furrows and with a high wax layer. ‘CTC91087-6’ plants exhibit a round bud shape with an apical pore. Leaf architecture is erect with wide leaves. The average auricle shape is lanceolate with asymmetric distribution, presenting crescent-shaped ligule. 
     The average mature stalk height (330 Harvest Day after Planting—DAP; measured from the crown until the insertion of leaf +1), stalk diameter (5° stalk; average from 10 cane), number of tillers (at 120 DAP and 330 DAP), weight (330 DAP; 10 tillers), sugar content (BRIX %; 330 DAP; from extracted juice), flowering (330 DAP) and phenological status (measured by the number of tillers per ratoon) were evaluate in five different locations in comparison with the parental variety ‘CTC9001’. 
     For each data set, data across all sites were combined for statistical analysis. Combined site analysis was done using the following statistical model: 
     
       
         
           
             
               
                 y 
                 ijk 
               
               = 
               
                 μ 
                 + 
                 
                   S 
                   i 
                 
                 + 
                 
                   
                     B 
                     ⁡ 
                     
                       ( 
                       S 
                       ) 
                     
                   
                   ij 
                 
                 + 
                 
                   G 
                   k 
                 
                 + 
                 
                   
                     ( 
                     SG 
                     ) 
                   
                   ik 
                 
                 + 
                 
                   ɛ 
                   ijk 
                 
               
             
             , 
           
         
       
     
     wherein y ijk  is the measurement of replicate j on site i for treatment k; μ is the overall mean; S i  is the effect of site i (i=1 to 5); B j  is the effect of replicate j (j=1 to 4); B(S) ij  is the effect of replicate j on site i (j=1 to 4); G k  is the effect of the treatment k (k=1 to 7 or 8); (SG) ik  is the interaction between site i and treatment k; ε ijk  is the experimental residual error. 
     The main effects analysis and model interaction were performed as described by Kuznetsova et al. (2017). All data were analyzed using mixed linear model by package 1me4 (Bates et al., 2015). 
     The results of the agronomic and phenotypic characteristics analysis are shown in the table below and corroborate the conclusion that ‘CTC91087-6’ is substantially equivalent to its parental non-transgenic variety (‘CTC9001’). 
     
       
         
           
               
             
               
                 TABLE 01 
               
             
            
               
                   
               
               
                 Average of agronomic and phenotypic characteristics for 
               
               
                 ‘CTC91087-6’ and ‘CTC9001’ parental (non-transgenic) variety.  
               
               
                 Combined analysis of five locations: Barrinha-SP,  
               
               
                 Camamu-BA, Piracicaba-SP, Quirinópolis-GO e Valparaiso-SP. 
               
            
           
           
               
               
               
               
               
            
               
                   
                   
                 Mean 
                   
                 Range* 
               
            
           
           
               
               
               
               
               
               
               
            
               
                   
                 Parameter 
                 CTC91087-6 
                 CTC9001 
                 SE 
                 Min 
                 Max 
               
               
                   
               
            
           
           
               
               
               
               
               
               
               
            
               
                 Com- 
                 Height (m) 
                 2.2 
                 2.1 
                 0.16 
                 1.9 
                 2.1 
               
               
                 bined 
                 Diameter (cm) 
                 2.9 
                 3.0 
                 0.32 
                 2.7 
                 3.4 
               
               
                 analysis 
                 Tillers (120 DAP) 
                 81.4 
                 72.8 
                 17.9 
                 57.2 
                 95.5 
               
               
                   
                 Tillers (330 DAP) 
                 75.8 
                 66.8 
                 20.2 
                 66.8 
                 88.4 
               
               
                   
                 Weight (Kg) 
                 11.2 
                 12.4 
                 1.31 
                 9.3 
                 12.9 
               
               
                   
                 BRIX (%) 
                 17.3 
                 17.2 
                 0.70 
                 14.8 
                 18.1 
               
               
                   
                 Phenological 
                 13.3** 
                 11.1 
                 3.33 
                 11.5 
                 14.6 
               
               
                   
                 status*** 
                   
                   
                   
                   
                   
               
               
                   
                 Flowering 
                 0 
                 0 
                 — 
                 0 
                 0 
               
               
                   
               
               
                 *Estimated based on the minimal and maximum observed values for 4 different commercial reference varieties cultivated in the same experimental conditions. 
               
               
                 **Statistical difference (T-test; p ≤ 0.05). 
               
               
                 ***Phenological status: the average number of tillers per ratoon was measured each 30 days (11 evaluations over the cycle). The average number of tillers/ratoon was higher for CTC91087-6 event in comparison to CTC9001 (13.30 vs. 11.0 un.), but it is still within the range of the commercial references. 
               
            
           
         
       
     
     Other compositional studies have been made and also demonstrated that ‘CTC91087-6’ is substantially equivalent to its conventional (non transgenic) counterpart ‘CTC9001’ [compositional parameters related to nutrition and the use of sugarcane in the diet, as defined by the OECD Guidance Document (OECD, 2011)]. Based on the results of combined data analysis (five representative locations in the Brazilian sugarcane growing regions), there were no statistically significant differences (p≤0.05) in any comparison of nutritional components between ‘CTC91087-6’ and the conventional counterpart ‘CTC9001’ (Table 02). The results also indicate that ‘CTC91087-6’ expresses Cry1Ac preferentially in leaves at levels required to control borer throughout sugarcane cultivation cycle and that no unintended effects of the genetic modification influencing plant metabolism have occurred. 
     
       
         
           
               
             
               
                 TABLE 02 
               
             
            
               
                   
               
               
                 Mean values of compositional parameters  
               
               
                 measured in genetically-modified event 
               
               
                 ‘CTC91087-6’ and conventional counterpart ‘CTC9001’. 
               
            
           
           
               
               
               
               
            
               
                   
                   
                 Mean 
                 Range* 
               
            
           
           
               
               
               
               
               
               
            
               
                   
                 Analyte 
                 CTC91087-6 
                 CTC9001 
                 Min 
                 Max 
               
               
                   
               
            
           
           
               
               
               
               
               
               
            
               
                 Com- 
                 Dry matter 
                 23.48 ± 1.06 
                 22.73 ± 1.06 
                 20.20 
                 22.77 
               
               
                 bined 
                 Moisture 
                 76.29 ± 0.81 
                 76.33 ± 0.81 
                 76.05 
                 78.96 
               
               
                 analysis 
                 Crude protein 1   
                  3.38 ± 0.23 
                  3.56 ± 0.23 
                 2.79 
                 4.65 
               
               
                   
                 Crude fat 1   
                  1.19 ± 0.11 
                  1.10 ± 0.11 
                 0.63 
                 1.27 
               
               
                   
                 Ash 1   
                  3.05 ± 0.41 
                  3.26 ± 0.41 
                 3.02 
                 4.34 
               
               
                   
                 Crude fiber 1   
                 25.82 ± 0.79 
                 27.33 ± 0.79 
                 23.91 
                 31.32 
               
               
                   
                 NDF 1   
                 47.79 ± 1.27 
                 50.91 ± 1.27 
                 46.07 
                 56.89 
               
               
                   
                 ADF 1   
                 31.10 ± 0.77 
                 32.95 ± 0.77 
                 29.30 
                 37.29 
               
               
                   
                 Sucrose 2   
                 11.63 ± 0.84 
                 12.17 ± 0.84 
                 9.20 
                 12.28 
               
               
                   
                 Glucose 2   
                  0.91 ± 0.12 
                  0.91 ± 0.12 
                 0.62 
                 1.11 
               
               
                   
                 Fructose 2   
                  0.75 ± 0.09 
                  0.76 ± 0.09 
                 0.55 
                 0.84 
               
               
                   
               
               
                   1 Results are expressed on dry weight basis; 
               
               
                   2 Values expressed sugarcane stalk basis; 
               
               
                   3 Minimum and maximum mean values of four commercial reference cultivars; 
               
               
                 SEM: Standard Error of the Mean. 
               
               
                 No significant difference between ‘CTC91087-6’ and conventional counterpart ‘CTC9001’ according to t-test at p ≤ 0.05. 
               
            
           
         
       
     
     EXAMPLES 
     Example 1. CTC91087-6 Event Generation— Agrobacterium  Transformation 
     Event CTC91087-6 was obtained by  Agrobacterium  tumefasciens-mediated genetic transformation of the CTC9001 cultivar. 
     The CTC9001 cultivar is a commercial hybrid developed by CTC and is the donor genotype of the CTC91087-6 event genetic background; that is, it represents the untransformed counterpart of the CTC91087-6 event. This cultivar has early maturation and is recommended for planting in the Brazilian states of Sao Paulo, Mato Grosso, Mato Grosso do Sul, Minas Gerais, Goias and Northeast Brazil (BRASIL, 2012). As with other commercial sugarcane hybrids, it is high-ploidy material with numerous chromosomes derived from its two parental varieties:  S. officinarum  and  S. spontaneum  (DANIELS and ROACH, 1987; SREENIVASAN et al., 1987). 
     CTC91087-6 event has the cry1Ac gene, which expresses a toxin to control  D. saccharalis , and the bar gene, used as a selection marker during the process of genetic modification. The expression of the cry1Ac and bar genes is regulated by the maize ubiquitin gene promoter UBI-1, which has an endogenous intron. Both expression cassettes use the  Agrobacterium tumefaciens  nopaline synthase (nos) terminator. 
     1.1 Construct Development Using cry1Ac and Bar Genes ( FIG. 5 ; SEQ ID NO 14). 
     Conventional gene cloning techniques using commercial bacterial plasmids, restriction enzyme digestion, and fragment ligation (with ligases) were used to develop the construct of the present invention ( FIG. 5 ). 
     The construct of the present invention was developed by joining the UBI-cry1Ac-NOS and UBI-bar-NOS cassettes. T-DNA containing both cassettes was transferred from a cloning plasmid to the base plasmid ( FIG. 4 : binary plasmid vector, which contains in its host spectrum the bacteria  Escherichia coli  and  Agrobacterium tumefaciens ) using restriction enzymes, generating the construct of the present invention ( FIG. 5 ; SEQ ID NO: 14). 
     After the final cloning step, the construct (SEQ ID NO: 14) was inserted into  Escherichia coli  strain DH5a using electroporation. An isolated colony containing the construct was inoculated into liquid LB medium supplemented with 150 μg/ml spectinomycin and incubated at 37° C. while shaking at 250 rpm for a period of 16 hours. Stocks were then prepared containing bacterial suspension and 10% (v/v) glycerol, which were stored in an ultrafreezer at −80° C. 
     The construct of the present invention was then transferred from  E. coli  to  Agrobacterium tumefaciens  strain EHA105 by isolation and purification of plasmid DNA and transformation of  Agrobacterium  by electroporation. As with the  E. coli  strain, stocks containing the bacterial suspension of  Agrobacterium  and 10% (v/v) glycerol were stored in an ultrafreezer at −80° C. 
     1.2  Agrobacterium -Mediated Plant Transformation 
     To obtain embryogenic callus, young CTC9001 sugarcane palm leaves, grown in the field or greenhouse for up to 12 months, were collected for isolation of the initial explants. 
     After surface disinfection, transverse sections about 0.05-5 mm thick were cut from above the meristem under aseptic conditions. The sections were placed on the surface of the callus induction culture medium [Sais M S—Murashige and Skoog, 1962; sucrose, vitamins B5, amino acids selected from the group comprising proline, casein hydrolyzate, citric acid, mannitol, copper sulfate, glycine, gelling agent, 2,4D]. The cultures were kept in the dark at 26±2° C. and sub-cultured every 15 days for three to five cycles of 7-28 days each. One week before transformation, calli were again selected for embryogenic characteristics (nodular, compact, opaque and slightly yellowish). 
       Agrobacterium  culture, comprising strain EHA105 transformed with the construct of the present invention, was started from a glycerol stock and kept in the dark at 28° C. for two to three days. The  Agrobacterium  suspension to infect plant material was prepared by resuspending the culture in MS liquid medium plus acetosyringone, adjusting to a final OD600 of 0.1-1.0 (MS salts, sucrose, and vitamins B5). 
     The calli with embryogenic characteristics were visually selected and directly transferred to the  Agrobacterium  suspension, where they remained for 30 minutes in the dark with constant agitation at 50 rpm. 
     After this period, calli were separated from the  Agrobacterium  suspension and excess suspension was removed. Next, calli were cultured for 1-5 days in semi-solid (MS salts, sucrose, vitamins B5, citric acid, gelling agent, 2,4D and acetosyringone) at 22° C. in the dark. 
     After co-cultivation, callus was transferred to DT rest medium (MS salts; sucrose, B5 vitamins, amino acids selected from the group comprising proline and asparagine, casein hydrolyzate, citric acid, copper sulfate, glycine, gelling agent, 2,4D, timentin) and kept for 5-14 days at 26° C. in the dark. 
     Transformed cells were selected by successive sub-cultures in selection culture medium containing phytoregulators and the selective agent ammonium glufosinate. (Selection medium with ammonium glufosinate: MS salts, sucrose, vitamins B5, amino acids selected from the group comprising proline and asparagine, casein hydrolyzate, copper sulfate, glycine, gelling agent, 2,4D, timentin) The calli remained in this condition for 21 days at 26° C. in the dark, then the calli were transferred to the regeneration medium (equivalent to selection medium without 2,4D) and then to elongation medium (MS salts, sucrose, B5 vitamins, casein hydrolyzate, gelling agent, timentin). The calli were exposed to a 16-hour photoperiod at 4,000 lux in the presence of the herbicide used as a selective agent, then they were multiplied, rooted, and acclimatized before transfer to the greenhouse. This process was used to generate the clone that eventually created the event CTC91087-6. 
     Example 2. Molecular Characterization of Event CTC91087-6 
     2.1 DNA Extraction. 
     Approximately 10 mg of leaf tissue from event CTC91087-6 was used. Genomic DNA extraction was performed on the BioSprint 96 Nucleic Acid Extractor (Quiagen, GER) with the BioSprint 96 DNA Plant Kit Extraction Kit (Quiagen, GER) according to the manufacturer&#39;s instructions. The DNA was normalized to a concentration of 10 ng/μL in a Multiskan GO spectrometer (Thermo Scientific, USA). 
     2.2 Determination of the Number of Transgene Copies Inserted into the Host Plant Germplasm. 
     The copy number of cry1Ac and bar genes inserted into CTC91087-6 event was initially evaluated by quantitative Taqman® PCR (qPCR/Taqman®), and the results were confirmed via Southern blot and/or sequencing. 
     The Taqman® real time PCR reactions were realized with 7500 Real-Time PCR System (Applied Biosystems, EUA) in the Fast mode. The primer pairs and probes used are shown at Table 03. As endogenous control of the cry1 Ac and bar reactions to confirm the presence and quality of the used DNA, as well as, effectiveness of the reaction, it was used the sugarcane polyubiquitin gene (forward primer: 5′ACCATTACCCTGGAGGTTGAGA 3′; antisense initiator: 5′GTCCTGGATCTTCGCCTTCA 3′; probe: VIC-5′CTCTGACACCATCGAC 3′-MGB) in multiplex mode. 
     
       
         
           
               
             
               
                 TABLE 03 
               
             
            
               
                   
               
               
                 Primers and probes (Taqman ®) used to determine copy number via qPCR. 
               
            
           
           
               
               
               
               
               
            
               
                 Assay 
                 Primers/probe 
                 Sequence 
                 Target 
                 Amplicon 
               
               
                   
               
               
                 UBI-cry 
                 Ubi.BAR.CN.Fw 
                 GCTCACCCTGTTGTTTGGTGTT 
                 cry1Ac 
                 69 bp 
               
               
                   
                   
                 (SEQ ID NO: 40) 
                   
                   
               
               
                   
                 CRY.4- 
                 TCGTTGATGTTTGGGTTGTTGT 
                   
                   
               
               
                   
                 ubi.CN.Rv 
                 (SEQ ID NO: 41) 
                   
                   
               
               
                   
                 Ubi.BAR_probe 
                 FAM-CTTCTGCAGGTCGACTC- 
                   
                   
               
               
                   
                   
                 MGB (SEQ ID NO: 42) 
                   
                   
               
               
                   
               
               
                 cry-cry 
                 CRY.571.CN.Fw 
                 AGCCGCTACAACGACCTGA 
                 cry1Ac 
                 79 bp 
               
               
                   
                   
                 (SEQ ID NO: 43) 
                   
                   
               
               
                   
                 CRY.649.CN.Rv 
                 GCTCCAGGCCGGTGTTG (SEQ ID 
                   
                   
               
               
                   
                   
                 NO: 44) 
                   
                   
               
               
                   
                 CRY.probe 
                 FAM- 
                   
                   
               
               
                   
                   
                 GGCAACTACACCGACCACGC- 
                   
                   
               
               
                   
                   
                 MGB (SEQ ID NO: 45) 
                   
                   
               
               
                   
               
               
                 UBI-bar 
                 Ubi.BAR.CN.Fw 
                 GCTCACCCTGTTGTTTGGTGTT 
                 bar 
                 62 bp 
               
               
                   
                   
                 (SEQ ID NO: 46) 
                   
                   
               
               
                   
                 Ubi.BAR.CN.Rv 
                 CGTCGTTCTGGGCTCATTCT 
                   
                   
               
               
                   
                   
                 (SEQ ID NO: 47) 
                   
                   
               
               
                   
                 Ubi.BAR_probe 
                 FAM-CTTCTGCAGGTCGACTC- 
                   
                   
               
               
                   
                   
                 MGB (SEQ ID NO: 48) 
               
               
                   
               
            
           
         
       
     
     The qPCR reactions used 1× TaqMan® Fast PCR Master Mix II (Applied Biosystems, USA), 300 nM from each primer and 200 nM from the corresponding probes. The cycling used was: a 50° C. cycle for 2 minutes for uracil N-glycosylase activation, a 95° C. cycle for 20 seconds for DNA polymerase activation, 40 cycles of 95° C. for 3 seconds (denaturation), and 60° C. for 30 seconds (annealing and extension). 
     Data analysis was performed by manually entering the threshold at the exponential phase of the amplification curve. For cry1Ac and bar genes, the copy number was inferred from DeltaCt (dCt) analysis, in which the Ct (cycle at which the fluorescence signal emitted by the amplification product reaches the threshold) of the endogenous gene is subtracted from the Ct of the target gene. In this type of analysis, the number of copies is assumed to double every Ct and the reference number of control copies of the same variety whose value is known is taken as a reference. 
     As a result, both assays pointed to the presence of 1 copy for the cry1Ac gene in the CTC91087-6 event genome. The same copy number (i.e., 1 copy) was detected for the bar gene, the assay of which is based on detection of the gene promoter. 
     2.3 Definition of Flanking Sequences. 
     To isolate the flanking regions at the ends of the T-DNA insert present in event CTC91087-6, several DNA sequencing experiments were performed. The map of the genetic insertion of event CTC91087-6 generated from the data of these experiments is shown in  FIG. 3 . 
     Inverse PCR (iPCR) assays were performed for both ends of the T-DNA to isolate and clone the flanking regions of the insert. The iPCR methodology is based on genomic DNA digestion using enzymes that cleave the T-DNA sequence and a random event genome sequence. The cleavage products are circularized and subjected to multiple nested PCR cycles using primers for known T-DNA regions (Table 04). The isolated fragments were then isolated, cloned and sequenced by Sanger methodology. Finally, a consensus sequence of the flanking regions was assembled (SEQ ID NO: 23 and SEQ ID NO: 24). 
     
       
         
           
               
             
               
                 TABLE 04 
               
               
                   
               
               
                 Restriction enzymes and primer sequences used for carrying out iPCR reactions 
               
               
                 and amplification reaction conditions. 
               
               
                   
               
             
            
               
                   
               
            
           
           
               
               
               
            
               
                 T-DNA 
                 Restriction 
                   
               
               
                 Edge 
                 Enzyme 
                 Oligonucleotide Sequence 
               
               
                   
               
            
           
           
               
               
               
               
            
               
                 Left 
                 BsrG1 
                 Nested PCR1 
                 5′-TGCAATGCTCATTATCTCTAG-3′ 
               
               
                   
                   
                   
                 (SEQ ID NO: 49) 
               
               
                   
                   
                   
                 5′-AGCATCACCATCTACACCGAC-3′ 
               
               
                   
                   
                   
                 (SEQ ID NO: 50) 
               
               
                   
                   
                 Nested PCR2 
                 5′-TGCACTGCAGGCATCGATC-3′ (SEQ 
               
               
                   
                   
                   
                 ID NO: 51) 
               
               
                   
                   
                   
                 5′-AGCATCACCATCTACACCGAC-3′ 
               
               
                   
                   
                   
                 (SEQ ID NO: 50) 
               
               
                   
                   
                 Nested PCR3 
                 5′-GATATCAGTACTAATTCAGTAC-3′ 
               
               
                   
                   
                   
                 (SEQ ID NO: 52) 
               
               
                   
                   
                   
                 5′-AGCATCACCATCTACACCGAC-3′ 
               
               
                   
                   
                   
                 (SEQ ID NO: 50) 
               
               
                   
               
               
                 Left 
                 Ndel 
                 Nested PCR1 
                 5′-TGCACTGCAGGCATCGATC-3′ (SEQ 
               
               
                   
                   
                   
                 ID NO: 53) 
               
               
                   
                   
                   
                 5′-ACGGATGCGACCTGTACG-3′ (SEQ 
               
               
                   
                   
                   
                 ID NO: 54) 
               
               
                   
                   
                 Nested PCR2 
                 5′-TGCACTGCAGGCATCGATC-3′ (SEQ 
               
               
                   
                   
                   
                 ID NO: 55) 
               
               
                   
                   
                   
                 5′-ACGGATGCGACCTGTACG-3′ (SEQ 
               
               
                   
                   
                   
                 ID NO: 54) 
               
               
                   
                   
                 Nested PCR3 
                 5′-GATATCAGTACTAATTCAGTAC-3′ 
               
               
                   
                   
                   
                 (SEQ ID NO: 56) 
               
               
                   
                   
                   
                 5′-ACGGATGCGACCTGTACG-3′ (SEQ 
               
               
                   
                   
                   
                 ID NO: 54) 
               
               
                   
               
               
                 Right 
                 KpnI 
                 Nested PCR1 
                 5′-AATTATACATTTAATACGCG-3′ 
               
               
                   
                   
                   
                 (SEQ ID NO: 57) 
               
               
                   
                   
                   
                 5′-AATAACGTCATGCATTACATG-3′ 
               
               
                   
                   
                   
                 (SEQ ID NO: 58) 
               
               
                   
                   
                 Nested PCR2 
                 5′-CGCGGTGTCATCTATGTTAC-3′ 
               
               
                   
                   
                   
                 (SEQ ID NO: 59) 
               
               
                   
                   
                   
                 5′-GATAATCATCGCAAGACCGG-3′ 
               
               
                   
                   
                   
                 (SEQ ID NO: 60) 
               
               
                   
                   
                 Nested PCR3 
                 5′-TCGTCGACTCTAGACTCGAG-3′ 
               
               
                   
                   
                   
                 (SEQ ID NO: 61) 
               
               
                   
                   
                   
                 5′-CGATCTCAGATCTCGGTGAC-3′ 
               
               
                   
                   
                   
                 (SEQ ID NO: 62) 
               
               
                   
               
            
           
           
               
               
               
               
            
               
                 Cycle Number 
                 Denaturation 
                 Ringing 
                 Extension 
               
               
                   
               
               
                 1st 
                 94° C., 5 min 
                 — 
                 — 
               
               
                   
               
               
                 2-36th 
                 94° C., 30 sec 
                 50° C. 45 sec 
                 72° C., 3 min 
               
               
                   
               
               
                 37th 
                 — 
                 — 
                 72° C., 7 min 
               
               
                   
               
            
           
         
       
     
     In parallel, as there is currently no fully sequenced genome that could be used as a reference for CTC9001 germplasm, a capture sequencing methodology was adopted as an additional effort to isolate the T-DNA inserted into the event CTC91087-6 and its flanking regions. In this strategy, small overlapping polynucleotide fragments (probes) were developed to cover the entire T-DNA sequence. These probes were hybridized to the fractionated genomic DNA of both CTC9001 and CTC91087-6 cultivars, and hybrid sequences were isolated. Isolated fragments were then sequenced using Illumina® technology according to standard protocol. The data obtained were aligned with the T-DNA sequence present in the transformation vector and, together with the iPCR data mentioned above, the complete T-DNA consensus sequence (SEQ ID NO: 2) of the CTC91087-6 event and its flanking sequences (SEQ ID NO: 22, SEQ ID NO: 5, SEQ ID NO: 23, SEQ ID NO: 24) were obtained. 
     2.4 Method for the Detection and Characterization of Event CTC91087-6 (Event-Specific Assay) 
     For the validation of the methodology, we used samples of event leaves from four different locations (Piracicaba, Barrinha, and Valparaiso (São Paulo); and Quirinópolis (Goiás). Both untreated control (WT) plants and other genetically-modified events having the same construct were used as experimental controls. DNA extraction occurred as described above. 
     Real-time PCR assays for identification of the CTC91087-6 event were designed and validated based upon the molecular characterization of the T-DNA insertion genomic flanking sequences. For the development of specific detection methodology, the real-time PCR (qPCR) technique known as “Plus-Minus” or “Presence—Absence” was chosen, validating the two variations of the methodology: via SYBR GREEN™ and via Taqman® technology. Specific primer pairs have been designed to generate information about the insertion of T-DNA in both methodologies, such that one primer binds in the construct and the second primer binds in the host genome. For the use of Taqman® technology, specific probes were designed between the primers. 
     In a preferred embodiment, the probe employed in Taqman® PCR technology consists of SEQ ID NO: 10 in the RB region and/or SEQ ID NO: 11 in the LB region. 
     Taqman® real-time PCR reactions were performed using the 7500 Real-Time PCR System (Applied Biosystems, USA) in its Fast mode. 
     The sugarcane poly-ubiquitin gene (endogenous gene) was used as an internal reaction control to confirm the presence and quality of the DNA used. The following reagents were multiplexed with the assay developed for the event: forward primer (SEQ ID NO: 15); reverse primer (SEQ ID NO: 16); probe (SEQ ID NO: 17). 
     qPCR reactions used 1× TaqMan® Fast PCR Master Mix II (Applied Biosystems, USA), 150 nM from each event-specific primer and 100 nM from the corresponding probe, 300 nM from the primers for the endogenous poly-ubiquitin gene and 300 nM of its probe, 100-200 ng of DNA and enough water to complete the 20 μL volume. The following PCR program was used: a 50° C. cycle for 2 minutes for uracil N-glycosylase activation, a 95° C. cycle for 20 seconds for DNA polymerase activation, 40 cycles of 95° C. for 3 seconds (denaturation) and 87° C. for 30 seconds (annealing and extension). 
     qPCR reactions using SYBR GREEN™ were also performed using the 7500 Real-Time PCR System (Applied Biosystems, USA) in its standard mode for this type of assay. Reactions were performed using 1× QuantiFast SYBR Green™ PCR Kit (QIAGEN™), 40 nM RB forward primer and 28 nM RB reverse primer, 100-200 ng DNA and sufficient water for a final volume of 25 μL. The reactions were performed using the event of the invention, the other events transformed with the same construct as the event of the invention (negative controls), wild sugarcane (WT) samples, and experimental controls (extraction and reaction blank). 
     The following PCR program was used: a DNA denaturation cycle at 95° C. for 5 minutes, 35 primer annealing cycles and amplification at 95° C. for 15 seconds and 60° C. for 1 minute and a dissociation cycle for generation melting peak (95° C. for 15 sec, 60° C. for 1 min, 95° C. for 15 sec and 60° C. for 15 sec). The reaction with SYBR safe does not allow for the use of multiplex; therefore it is necessary to prepare a seperate endogenous gene amplification reaction, using the same DNA, to eliminate false negatives. 
     As a result, it was possible to validate the event-specific detection reaction of the invention via high-accuracy Taqman®, as illustrated in  FIG. 6 . 
     Samples corresponding to the event of the invention showed specific amplification: having well-defined amplification curve formation and characteristic sigmoidal shape; whereas samples from other events, WT, and extraction and reaction blanks did not show event-specific amplification. As expected, the endogenous control presented amplification for all samples except extraction and reaction blanks, demonstrating both the quality of the DNA used in the reaction, as well as the quality of the reaction and cycling. 
     The SYBR GREEN™ assay showed specific amplification of the event samples at the expected melting temperature (83.5° C.). Samples of the other events, as well as WT and blanks did not peak at this temperature, although some samples of the event of interest showed a lower intensity curve before the specific peak ( FIG. 7 ). Such a curve is characteristic of primer dimer formation during the PCR reaction, which would be expected because the technology is based on the binding of an intercalating agent to any double stranded DNA molecules—whether derived from specific amplification or binding between the primers. In contrast, Taqman® technology probes specifically bind to DNA and are released during DNA amplification, thus generating the fluorescence signal captured by the equipment during this process. 
     Example 3. Event CTC91087-6 Generation—Genome Editing (GE) 
     The event of the invention, CTC91087-6, is generated using a genome editing (GE) approach, thus recreating the event generated using the preferred  Agrobacterium -mediated transformation methods described herein. 
     In this way, the event CTC91087-6 is recreated with the insertion of the cry1Ac gene into the same location of the genome as the CTC91087-6 event. Cry1Ac gene expression is regulated by a promoter or a promoter region and a terminator capable to drive the Cry1Ac protein expression at levels sufficient to control infestation of the target pest. Additionally, a marker gene or selection system is also inserted (transiently or stably) to enable event selection. Preferably, the T-DNA of the claimed invention (SEQ ID NO: 2) is inserted into the same location of the genome as the CTC91087-6 event. Thus, the event CTC91087-6 is recreated with the insertion of the cry1Ac gene, which expresses a toxin to control  D. saccharalis , and the bar gene. The expression of the cry1Ac and bar genes is regulated by the maize ubiquitin gene promoter UBI-1, which has an endogenous intron. Both expression cassettes use the  Agrobacterium tumefaciens  nopaline synthase (nos) terminator. 
     In the case that the aforementioned genome editing approaches to generating event CTC91087-6 result in low-efficiency integration of the T-DNA at the target site, developmental genes or other regulatory elements could be delivered in conjunction with the GE reagents in order to improve the integration efficiency. 
     3.1 Constructs Development. 
     Conventional gene cloning techniques using commercial plasmids, restriction enzyme digestion, fragment ligation (with ligases) and other known methodologies are used to develop the constructs (plasmids) of the present invention. 
     The GE reagents can be delivered on multiple plasmids, each one comprised of an element of the enzymatic complex (endonuclease, crRNA or guide RNA, and the homologous recombination (HR) template;  FIG. 21 ). 
     In one embodiment, the HR template constructs comprises the T-DNA (SEQ ID NO: 2) of the claimed invention flanked by approximately 1 kb of DNA homologous to the flanking sequences described for CTC91087-6 (SEQ ID Nos: 23 and 24) located on either side of the T-DNA. In a preferred embodiment, the HR template constructs comprises the SEQ ID NO: 26 ( FIG. 21 ). The invention also comprises a second construct comprising an endonuclease expression cassette. In a preferred embodiment, the endonuclease expression cassette comprises a Cas9 endonuclease sequence. In more preferred embodiment the Cas9 sequence is codon optimized for sugarcane expression. In one embodiment, the Cas 9 construct comprises additionally the guide/crRNA sequence. Preferably, the Cas 9 construct comprises the crRNA sequence SEQ ID NO: 28. In a more specific embodiment, the Cas 9 construct comprises the SEQ ID NO: 27 ( FIG. 20 ). A third construct comprising the guide RNA expression cassette alone is also contemplated in the present invention and comprises SEQ ID NO: 28. 
     In one additional embodiment the genome editing construct comprises HR template, the nuclease and the guide RNA expression cassettes, delivering all the GE reagents in a single construct. In one embodiment, the single construct comprises the T-DNA (SEQ ID NO: 2) of the claimed invention flanked by approximately 1 kb of DNA homologous to the flanking sequences described for CTC91087-6 (SEQ ID Nos: 23 and 24) located on either side of the T-DNA. In a preferred embodiment, the construct comprises the SEQ ID NO: 25 ( FIG. 22 ). 
     Optionally, the constructs also comprise fluorescent/selection markers and/or other genetic engineering systems to remove marker genes and/or nucleases cassettes, such as a Cre/loxP recombination system from the bacteriophage P1. In this case, the marker/nuclease gene cassette, which should be deleted, is flanked by the loxP regions, while Cre recombinase removes this fragment during a transient expression. 
     3.2 Direct Delivery 
     In one embodiment, the event of the invention is generated using methodologies for direct delivery of proteins, RNA or plasmids. The methodologies for direct delivery are selected from the group consisting of particle bombardment, electroporation, lipofection and protoplast transfection; however, other delivery methodologies known to those of skill in the art could also be utilized. 
     3.2.1 Direct Delivery—RNP Approach 
     In one embodiment, the event of the invention is generated using ribonucleoprotein (RNP) delivery. The preferred methodologies for RNP delivery are selected of the group consisting of particle bombardment of sugarcane calli and protoplast transfection. Moreover, other sugarcane cell types can also be used for transformation including (but not limited to): leaf disc, meristem, and calli-derived suspension cells. 
     Using the RNP approach to genome editing, the endonuclease and crRNA or guide RNA are delivered in RNP form, separate from the HR template, which is delivered via plasmid. 
     The guide RNA may be preliminarily produced by in vitro transcription or be chemically synthesized as ribooligonucleotide, while the corresponding nuclease may be produced in vivo with further purification (bacterial expression) or purchased from any manufacturer of such products. In a preferred embodiment, the guide RNA comprises SEQ ID NO: 28. In another embodiment the nuclease is Cas9 nuclease. 
     A ready ribonucleoprotein (RNP) complex consisting of the corresponding nuclease and guide RNA, and the HR template plasmid are sorbed on golden particles and direct delivery to the cells or tissue. 
     3.2.2 Direct Delivery—Plasmid 
     In another embodiment of the invention, the event of the invention is generated using plasmid delivery, wherein the GE reagents will be expressed in a transient manner, thus achieving the site-directed integration of CTC91087-6 without the integration of additional transgenes associated with the GE approach. 
     Methodologies for plasmid delivery is selected from the group consisting of particle bombardment (biolistic) of sugarcane calli or polyethylene glycol transformation of protoplasts; however, other methodologies known to those of skill in the art could also be utilized. Moreover, other sugarcane cell types can also be used for transformation including (but not limited to): protoplast, leaf disc, meristem, and calli-derived suspension cells. 
     In yet another embodiment of the invention, the event of the invention is generated using plasmid delivery, where the GE reagents are stably expressed, thus requiring the excision of the integrated GE reagents and selectable marker using, for example, a Cre/Lox system. Using this approach, LoxP sites will remain in the genome of the event CTC91087-6 plant. Other DNA excision approaches known to those skilled in the art may also be used to remove the GE reagent DNA from the genome of the event CTC91087-6 plant. 
     3.3 Indirect Delivery 
     In one embodiment, the event of the invention is generated using methodologies for indirect delivery of plasmids, as  Agrobacterium  transformation.  Agrobacterium tumefaciens  and  Agrobacterium rhizogenes  can be used. Plant viruses also can be used for indirect delivery of plasmids to plant cells and tissues. For example, genetically modified plant geminiviruses make it possible to achieve higher transformation efficiency, specially without stable insertion into a genome. Moreover, different tissue and cell types can also be used for transformation including (but not limited to): calli, protoplast, leaf disc, meristem, and calli-derived suspension cells. 
     In a preferred embodiment the  Agrobacterium  transformation is performed as describe at Example 1. 
     In another preferred embodiment, the event of the invention is generated using plasmid delivery by  Agrobacterium  transformation, wherein the GE reagents will be expressed in a transient manner, thus achieving the site-directed integration of CTC91087-6 without the integration of additional transgenes associated with the GE approach. 
     The GE reagents can be delivered on multiple plasmids, but preferably on a single plasmid. In a preferred embodiment, the constructs is SEQ ID NO: 25 and comprises a selectable marker, a nuclease, crRNA or guide RNA, and homologous recombination (HR) template ( FIG. 22 ). The HR template comprises T-DNA (SEQ ID NO: 2) of the claimed invention flanked by approximately 1 kb of DNA homologous to the flanking sequences described for CTC91087-6 (SEQ ID Nos: 23 and 24) located on either side of the expression cassettes. 
     In a preferred embodiment, the event of the invention is generated using plasmid delivery, where the GE reagents are stably expressed, thus requiring the excision of the integrated GE reagents and selectable marker using, for example, a Cre/Lox system. Using this approach, LoxP sites will remain in the genome of the event CTC91087-6 plant. Other DNA excision approaches known to those skilled in the art may also be used to remove the GE reagent DNA from the genome of the event CTC91087-6 plant. 
     With all the transformation processes described above, the resulting transformed cells will be regenerated to form a plant containing the event of the invention. 
     3.4 Molecular Characterization. 
     The event CTC91087-6, generated using genome editing, is evaluated for accurate insertion of the T-DNA into the target site of the genome using the primers of the invention (SEQ ID NO: 6-9) as is described in the specification herein. 
     Additionally, pair of primers designed to amplify sequences next to 1 Kb region of event CTC91087-6 flanking sequences are validated to evaluated the integrity of the recombination site (Table 05). 
     
       
         
           
               
             
               
                 TABLE 05 
               
               
                   
               
               
                 Pair of primers designed for Flanking sequences of CTC91087-6 (1 Kb region). 
               
               
                   
               
             
            
               
                   
               
            
           
           
               
               
               
               
            
               
                   
                   
                   
                 Expected 
               
               
                   
                   
                   
                 amplicon sizes 
               
            
           
           
               
               
               
            
               
                   
                 Oligonucleotides 
                 flanking 
               
               
                 Name 
                 Sequence 
                 region 
               
               
                   
               
            
           
           
               
               
               
               
            
               
                 FS RB 
                 FS_C91-087_RB_1,4k.a 
                 5′-CAACAACCCAAACATCAACG-3′ 
                 1394 
               
               
                   
                   
                 (SEQ ID NO: 63) 
                   
               
               
                   
                   
                 5′-TAACATTTAGGGTGCGCTTG-3′ 
                   
               
               
                   
                   
                 (SEQ ID NO: 64) 
                   
               
               
                   
               
               
                 FS LB 
                 FS_C91-087_LB_2k.a 
                 5′-GTTCTTGGGTGGCGGTAGTA-3′ 
                 2054 
               
               
                   
                   
                 (SEQ ID NO: 65) 
                   
               
               
                   
                   
                 5′-CGTCGGTGTAGATGGTGATG-3′ 
                   
               
               
                   
                   
                 (SEQ ID NO: 66) 
                   
               
               
                   
                 FS_C91-087_LB_2k.b 
                 5′-TTGGGTGGCGGTAGTAGTTG-3′ 
                 2050 
               
               
                   
                   
                 (SEQ ID NO: 67) 
                   
               
               
                   
                   
                 5′-CGTCGGTGTAGATGGTGATG-3′ 
                   
               
               
                   
                   
                 (SEQ ID NO: 66) 
               
               
                   
               
            
           
           
               
               
               
               
            
               
                 Cycle Number 
                 Denaturation 
                 Ringing 
                 Extension 
               
               
                   
               
               
                 1st 
                 94° C., 1 min 
                 — 
                 — 
               
               
                   
               
               
                 2-30th 
                 98° C., 10 sec 
                 68° C. 9 min 
                 — 
               
               
                   
               
               
                 31th 
                 — 
                 — 
                 72° .C, 10 min 
               
               
                   
               
            
           
         
       
     
     Example 4. Evaluation of the Gene Expression Product Inserted in the Event of the Invention 
     The gene expression product in the event of the present invention has been characterized in detail using ELISA to determine the concentration of Cry1Ac and Pat proteins and Western blot to confirm the identities of these heterologous proteins. 
     (ELISA) Enzyme-Linked Immunosorbent Assay 
     To evaluate cry1Ac and bar gene expression via ELISA, different sugarcane tissues were studied at different stages of crop development. To produce tissue samples of the event of the invention and the parental control, three types of experimental tests were conducted: PACE, EB and AGROPHENO. 
     Together, the PACE and AGROPHENO trials were conducted at five representative sites of the parental control cultivation area, three in the state of Sao Paulo (Barrinha, Piracicaba and Valparaiso), one in the state of Goias (Quirinópolis), and one in the state of Bahia (Camamu). The experiments were conducted in a randomized complete block design with 4 replications. The plots were composed of four 12 meters rows (Barrinha, Piracicaba, Valparaiso and Quirinópolis) or of four 7 meters rows (Camamu). In all cases, the spacing between rows was 1.5 meter. 
     EB assays were performed at four sites, three in the state of Sao Paulo (Barrinha, Piracicaba and Valparaiso) and one in the state of Goias (Quirinópolis). The experiments were conducted in a randomized block design with 4 replications. The plots consisted of 4 rows of 4 meters each. In all cases, the spacing between rows was 1.5 meter. Table 06 presents details of the tests performed at the respective locations. 
     
       
         
           
               
             
               
                 TABLE 06 
               
             
            
               
                   
               
               
                 Assay information used for sample collection for analysis  
               
               
                 of cry1Ac and bar gene expression produced by the event  
               
               
                 of the invention. (Number of Days After Planting  
               
               
                 (DAP) represents time of sample collection for analysis.) 
               
            
           
           
               
               
               
               
               
            
               
                 Assay Type 
                 Assay 
                 Location 
                 Tissue 
                 DAP 
               
               
                   
               
               
                 PACE/ 
                 PACE  
                 Barrinha-SP 
                 leaf 
                 100, 200, 300 
               
               
                 AGROPHENO 
                 CTC91-BA 
                   
                 stalk 
                 330 
               
               
                   
                   
                   
                 root 
                 330 
               
               
                   
                 PACE  
                 Piracicaba-SP 
                 leaf 
                 100, 200, 300 
               
               
                   
                 CTC91-PI 
                   
                 stalk 
                 330 
               
               
                   
                   
                   
                 root 
                 330 
               
               
                   
                 PACE  
                 Valparaiso-SP 
                 leaf 
                 100, 200, 300 
               
               
                   
                 CTC91-VP 
                   
                 stalk 
                 330 
               
               
                   
                   
                   
                 root 
                 330 
               
               
                   
                 PACE  
                 Quirinópolis- 
                 leaf 
                 100, 200, 300 
               
               
                   
                 CTC91-QS 
                 GO 
                 stalk 
                 330 
               
               
                   
                   
                   
                 root 
                 330 
               
               
                   
                 AGROPHENO 
                 Camamu-BA 
                 leaf 
                 100, 200, 300 
               
               
                   
                 CTC91-CA 
                   
                 stalk 
                 330 
               
               
                   
                   
                   
                 root 
                 330 
               
               
                 EB 
                 EB-BIO-BA 
                 Barrinha-SP 
                 leaf 
                 60, 120,  
               
               
                   
                   
                   
                   
                 240, 300 
               
               
                   
                 EB-BIO-PI 
                 Piracicaba-SP 
                 leaf 
                 60, 120,  
               
               
                   
                   
                   
                   
                 240, 300 
               
               
                   
                 EB-BIO-VP 
                 Valparaíso-SP 
                 leaf 
                 60, 120,  
               
               
                   
                   
                   
                   
                 240, 300 
               
               
                   
                 EB-BIO-QS 
                 Quirinópolis- 
                 leaf 
                 60, 120,  
               
               
                   
                   
                 GO 
                   
                 240, 300 
               
               
                   
               
            
           
         
       
     
     The expression analysis of Cry1Ac and Pat proteins produced by the event of the invention was investigated at different periods of sugarcane plant development. The conditions evaluated were:
         Expression of heterologous proteins in leaves over a cultivation cycle of the event of the invention (100, 200 and 300 DAP);   Expression of heterologous proteins in leaves along a sugarcane cycle at 60 and 120 DAP, then at 240 and 300 DAP;   Expression of heterologous proteins in stems and roots at 330 DAP of the sugarcane cycle.       

     Leaf samples were collected on experimental treatment plots (invention and parental control) in the PACE/AGROPHENO assays at 100, 200 and 300 DAP. In EB assays, samples were collected at 60, 120, 240, and 300 DAP. Thatched and root samples were collected only at 330 DAP in the PACE/AGROPHENO assays. After collection, the samples were sent for ELISA analysis to determine Cry1Ac and Pat protein expression levels. 
     Leaf Samples: 30 cm of tissue were collected from the tip of 5 to 10 “diagnostic” leaves on zigzag lines 2 and 3 avoiding diseased leaves. After removal of the central rib, the leaves were chopped into pieces, homogenized and packed in previously identified ziplock bags. 
     Stalk Samples: 10 whole sugarcanes were collected. After removing the dried leaves and pointers, the canes were cut into small tails, homogenized, and packed into labelled packages. 
     Root Samples: A representative clump from rows 2 and 3 of the experimental plot was collected. The soil was crushed, and the roots were washed with clean water to remove excess soil. The clean roots were then minced into pieces, homogenized, and packaged into labelled plastic bags. 
     All samples (from leaf, stem, and root tissues) were transferred to dry ice in a Styrofoam box within 15 min of collection. The genetic identity of all clumps sampled was confirmed by event-specific assay as described above. 
     30 mg of leaf, 60 mg of stem, and 200 mg of root tissue (frozen in dry ice or liquid nitrogen) were macerated using TissueLyser equipment. To the macerated leaf tissue was added 750 μl saline phosphate extraction buffer (PBS) supplemented with Tween 20 (0.138 M NaCl; 0.027 mM KCl; 0.05% Tween 20, pH 7.4) diluted according to manufacturer&#39;s instructions (Envirologix™, USA). For stalk and root, 375 μL of the same buffer was used. After buffer addition, vortex homogenization was performed and then centrifugation for 20 minutes at maximum speed. The resulting supernatant was collected and total protein was quantified using the Bradford assay. 
     Quantitation of Cry1Ac and Pat proteins was performed according to the recommendations of the ThermoScientific™ Coomassie Plus (Bradford) Protein Assay Kit (23236)—Microplate Procedure. Thus, the standards used for obtaining the calibration curve were the already-diluted commercial BSA (Bovine Serum Albumin) standards supplied with the kit described above. The 2000, 1000, 500, 250, 125, and 0 μg/mL calibrators (prepared in PBST buffer) were used. 10 μL of each standard calibrator was added in triplicate to plate wells. In total, 6 curves were generated from independent dilutions. For the samples, 10 μL of the 3 individual protein extractions were used in each well. Then 200 μL of Coomassie Plus Reagent Solution was added to each well containing the calibrators and samples. The plates were covered and incubated for 5 minutes at room temperature. Absorbance was read at 595 nanometers (nm) using SoftmaxPro 7.0 software (Molecular Device). 
     Total proteins were obtained in triplicate for each sample studied. After the total protein quantification of each replicate, the sample with the smallest variation of the median quantification value was chosen for ELISA analysis. These samples were normalized following the standard Qiagility Automatic Pipettor (QIAGEN) operating procedure. Normalization was done to a final concentration of 150 μg/mL total protein. Subsequently, the samples were diluted to ensure that the protein concentrations to be identified were within the reliable quantitation range. For analysis of the presence of Cry1Ac protein, the dilution was made to have 1.000 ng/mL. For the analysis of the presence of Pat protein, the dilution was to 30,000 ng/mL. Standard samples were used as previously described for ELISA analysis. 
     Results were obtained by 96-well plate spectrometry reading at two different wavelengths: 450 nm and 630 nm for Cry1Ac and 450 nm for Bar on a SpectraMax Plate reader (Molecular Devices). For Cry1Ac the Envirologix AP003 CRBS kit is used for protein detection and quantification. For Pat (bar) the Envirologix AP013 BAR kit was used. In all cases, the manufacturers recommendations were followed. 
     The analysis was based on the association of the absorbance values of the test samples with the predicted values in an equation estimated by measuring the absorbance of a standard curve. Synthetic proteins were diluted to desired concentrations in PBST buffer. Analyzes were performed in experimental duplicate for each sample. Cry1Ac and Pat protein concentrations were presented based on Total Protein (μg/mg), Fresh Tissue (μg/g) and Dry Tissue (μg/g). 
     Cry1Ac protein expression data from leaves of the event of the invention over one year of cultivation (110, 200, and 300 DAP) at each of the five sites evaluated are shown in Table 07 below. 
     
       
         
           
               
             
               
                 TABLE 07 
               
             
            
               
                   
               
               
                 Average Cry1Ac expression in leaves of the event of the invention over a year of sugarcane cultivation. 
               
               
                 Individual and combined statistical analysis for the 5 sites tested at 100, 200, and 300 DAP (SE: standard error). 
               
            
           
           
               
               
               
            
               
                   
                 Time 
                 Event of the Invention 
               
            
           
           
               
               
               
               
               
               
               
               
            
               
                   
                 DAP/ 
                 μg Cry1Ac/ 
                   
                 μg Cry1Ac/ 
                   
                 μg Cry1Ac/ 
                   
               
               
                 Location 
                 Comparison 
                 mg Total Protein 
                 SE 
                 g Fresh Tissue 
                 SE 
                 g Dry Tissue 
                 SE 
               
               
                   
               
            
           
           
               
               
               
               
               
               
               
               
            
               
                 Barrinha-SP 
                 100 
                 3.3 
                 0.19 
                 24.6 
                 3,32 
                 83.5 
                 10.80 
               
               
                   
                 200 
                 3.1 
                 0.19 
                 32.8 
                 3.32 
                 99.0 
                 10.80 
               
               
                   
                 300 
                 3.5 
                 0.19 
                 44.1 
                 3.32 
                 143.8 
                 10.80 
               
               
                 Camamu-BA 
                 100 
                 3.2 
                 0.12 
                 30.3 
                 1.96 
                 127.2 
                 6.62 
               
               
                   
                 200 
                 3.1 
                 0.12 
                 32.9 
                 1.96 
                 99.3 
                 6.62 
               
               
                   
                 300 
                 2.4 
                 0.12 
                 27.5 
                 1.96 
                 89.5 
                 6.62 
               
               
                 Piracicaba-SP 
                 100 
                 3.5 
                 0.17 
                 31.1 
                 2.84 
                 119.6 
                 10.40 
               
               
                   
                 200 
                 3.0 
                 0.17 
                 35.8 
                 2.84 
                 119.0 
                 10.40 
               
               
                   
                 300 
                 3.7 
                 0.17 
                 39.1 
                 2.84 
                 123.0 
                 10.40 
               
               
                   
                 100 
                 4.3 
                 0.19 
                 24.2 
                 1.57 
                 91.8 
                 5.24 
               
               
                 Quirinópolis-GO 
                 200 
                 2.8 
                 0.19 
                 22.1 
                 1.57 
                 65.9 
                 5.24 
               
               
                   
                 300 
                 2.8 
                 0.19 
                 28.1 
                 1.57 
                 89.8 
                 5.24 
               
               
                   
                 100 
                 3.6 
                 0.24 
                 24.3 
                 2.52 
                 91.7 
                 8.49 
               
               
                 Valparaíso-SP 
                 200 
                 3.3 
                 0.24 
                 25.5 
                 2.52 
                 85.2 
                 8.49 
               
               
                   
                 300 
                 3.7 
                 0.24 
                 27.7 
                 2.52 
                 91.9 
                 8.49 
               
               
                   
                 100 
                 3.6 
                 0.11 
                 26.9 
                 1.76 
                 102.8 
                 5.91 
               
               
                 Combined Analysis 
                 200 
                 3.0 
                 0.11 
                 29.8 
                 1.76 
                 93.7 
                 5.91 
               
               
                   
                 300 
                 3.2 
                 0.11 
                 33.3 
                 1.76 
                 107.6 
                 5.91 
               
               
                   
               
            
           
         
       
     
     Cry1Ac expression data (leaves) from the combined analysis of the 5 locations of the event of the invention over a year of cane cultivation (Table 07) are shown in  FIG. 8  (in μg protein/g dry tissue). 
     Cry1Ac protein expression data in leaves of the event of the invention over a cycle of cane 60 and 120 DAP and cane 240 and 300 DAP are presented in Table 08. 
     
       
         
           
               
             
               
                 TABLE 08 
               
             
            
               
                   
               
               
                 Comparison of means of Crt1Ac expression in leaves of the event of the 
               
               
                 invention over a cycle of cane 60 and 120 DAP and cane 240 and 300 DAP. 
               
            
           
           
               
               
               
            
               
                   
                 Time 
                 Event of the Invention 
               
            
           
           
               
               
               
               
               
               
               
               
            
               
                   
                 DAP/ 
                 μg Cry1Ac/ 
                   
                 μg Cry1Ac/ 
                   
                 μg Cry1Ac/ 
                   
               
               
                 Location 
                 Comparison 
                 mg Total Proteing 
                 SE 
                 g Fresh Tissue 
                 SE 
                 g Dry Tissue 
                 SE 
               
               
                   
               
            
           
           
               
               
               
               
               
               
               
               
            
               
                   
                 60 
                 3.2 
                 0.14 
                 37.4 
                 1.41 
                 142.7 
                 4.96 
               
               
                 Barrinha-SP 
                 120 
                 3.3 
                 0.14 
                 46.7 
                 1.41 
                 148.6 
                 4.96 
               
               
                   
                 240 
                 2.3 
                 0.14 
                 20.9 
                 1.41 
                 72.8 
                 4.96 
               
               
                   
                 300 
                 2.8 
                 0.14 
                 30.6 
                 1.41 
                 104.0 
                 4.96 
               
               
                   
                 60 
                 3.8 
                 0.29 
                 40.8 
                 5.05 
                 179.9 
                 15.40 
               
               
                 Piracicaba-SP 
                 120 
                 3.3 
                 0.29 
                 68.4 
                 5.05 
                 118.3 
                 15.40 
               
               
                   
                 240 
                 3.4 
                 0.29 
                 34.4 
                 5.05 
                 107.1 
                 15.40 
               
               
                   
                 300 
                 3.0 
                 0.29 
                 27.4 
                 5.05 
                 95.0 
                 15.40 
               
               
                   
                 60 
                 3.3 
                 0.15 
                 34.0 
                 2.39 
                 129.8 
                 7.89 
               
               
                 Quirinópolis-GO 
                 120 
                 3.0 
                 0.15 
                 51.2 
                 2.39 
                 163.7 
                 7.89 
               
               
                   
                 240 
                 2.0 
                 0.15 
                 20.2 
                 2.39 
                 75.7 
                 7.89 
               
               
                   
                 300 
                 2.4 
                 0.15 
                 28.0 
                 2.39 
                 87.9 
                 7.89 
               
               
                   
                 60 
                 3.0 
                 0.18 
                 32.8 
                 2.91 
                 143.7 
                 10.2 
               
               
                 Valparaíso-SP 
                 120 
                 2.3 
                 0.18 
                 38.1 
                 2.91 
                 122.1 
                 10.2 
               
               
                   
                 240 
                 2.0 
                 0.18 
                 16.7 
                 2.91 
                 62.0 
                 10.2 
               
               
                   
                 300 
                 2.7 
                 0.18 
                 30.6 
                 2.91 
                 97.3 
                 10.2 
               
               
                   
                 60 
                 3.3 
                 0.16 
                 36.3 
                 2.14 
                 147.0 
                 5.17 
               
               
                 Combined Analysis 
                 120 
                 3.0 
                 0.16 
                 50.3 
                 2.14 
                 139.5 
                 5.17 
               
               
                   
                 240 
                 2.4 
                 0.16 
                 22.7 
                 2.14 
                 77.5 
                 5.17 
               
               
                   
                 300 
                 2.8 
                 0.16 
                 29.7 
                 2.14 
                 96.1 
                 5.17 
               
               
                   
               
            
           
         
       
     
     Cry1Ac expression data (leaves) from the combined analysis of 4 locations of the event of the invention in a crop cycle of cane 60 and 120 DAP and cane 240 and 300 DAP (Table 4) are shown in  FIG. 9  (in μg protein/g dry tissue). 
     Cry1Ac protein expression data in mature stems from the event of the invention harvested at 330 DAP are shown in Table 09. 
     
       
         
           
               
             
               
                 TABLE 09 
               
             
            
               
                   
               
               
                 Comparison of average Cry1Ac expression in mature stems  
               
               
                 of the event of the invention harvested at 330 DAP. 
               
            
           
           
               
               
            
               
                   
                 Event of the Invention 
               
            
           
           
               
               
               
               
            
               
                 Location/ 
                 μg Cry1Ac/ 
                 μg Cry1Ac/ 
                 μg Cry1Ac/ 
               
               
                 Comparison 
                 mg Total Protein 
                 g Fresh Tissue 
                 g Dry Tissue 
               
               
                   
               
            
           
           
               
               
               
               
            
               
                 Barrinha-SP 
                 10.0 
                 3.9 
                 16.2 
               
               
                 Camamu-BA 
                 7.4 
                 3.6 
                 17.1 
               
               
                 Piracicaba-SP 
                 7.1 
                 2.5 
                 10.0 
               
               
                 Quirinópolis-GO 
                 9.7 
                 3.9 
                 16.0 
               
               
                 Valparaíso-SP 
                 10.0 
                 4.3 
                 17.6 
               
               
                 Standard Error 
                 1.1 
                 0.5 
                 2.3 
               
               
                   
               
            
           
         
       
     
     Cry1Ac expression data in mature stems from the event of the invention at 330 DAP (Table 09) are shown in  FIG. 10  (in μg protein/g dry tissue). 
     Pat protein expression data in leaves from the event of the invention over one year of cultivation (110, 200 and 300 DAP) for the five evaluated locations are presented in Table 10. 
     
       
         
           
               
             
               
                 TABLE 10 
               
             
            
               
                   
               
               
                 Comparison of average Pat expression from leaves of the event of the 
               
               
                 invention over a cane crop cycle (100, 200 and 300 DAP). 
               
            
           
           
               
               
               
            
               
                   
                 Time 
                 Event of the Invention 
               
            
           
           
               
               
               
               
               
               
               
               
            
               
                   
                 DAP/ 
                 μg Pat/ 
                   
                 μg Pat/ 
                   
                 μg Pat/ 
                   
               
               
                 Location 
                 Comparison 
                 mg Total Protein 
                 SE 
                 g Fresh Tissue 
                 SE 
                 g Dry Tissue 
                 SE 
               
               
                   
               
               
                 Barrinha-SP 
                 100 
                 0.03 
                 0.001 
                 0.20 
                 0.009 
                 0.69 
                 0.030 
               
               
                   
                 200 
                 0.01 
                 0.001 
                 0.12 
                 0.009 
                 0.37 
                 0.030 
               
               
                   
                 300 
                 0.01 
                 0.001 
                 0.16 
                 0.009 
                 0.53 
                 0.030 
               
               
                 Camamu-BA 
                 100 
                 0.01 
                 0.001 
                 0.11 
                 0.006 
                 0.45 
                 0.022 
               
               
                   
                 200 
                 0.01 
                 0.001 
                 0.10 
                 0.006 
                 0.29 
                 0.022 
               
               
                   
                 300 
                 0.01 
                 0.001 
                 0.06 
                 0.006 
                 0.20 
                 0.022 
               
               
                 Piracicaba-SP 
                 100 
                 0.03 
                 0.001 
                 0.26 
                 0.013 
                 0.98 
                 0.048 
               
               
                   
                 200 
                 0.01 
                 0.001 
                 0.16 
                 0.013 
                 0.52 
                 0.048 
               
               
                   
                 300 
                 0.01 
                 0.001 
                 0.14 
                 0.013 
                 0.44 
                 0.048 
               
               
                 Quirinópolis-GO 
                 100 
                 0.03 
                 0.001 
                 0.15 
                 0.009 
                 0.59 
                 0.034 
               
               
                   
                 200 
                 0.01 
                 0.001 
                 0.10 
                 0.009 
                 0.30 
                 0.034 
               
               
                   
                 300 
                 0.01 
                 0.001 
                 0.11 
                 0.009 
                 0.35 
                 0.034 
               
               
                 Valparaíso-SP 
                 100 
                 0.08 
                 0.002 
                 0.12 
                 0.011 
                 0.47 
                 0.039 
               
               
                   
                 200 
                 0.01 
                 0.002 
                 0.10 
                 0.011 
                 0.35 
                 0.039 
               
               
                   
                 300 
                 0.01 
                 0.002 
                 0.10 
                 0.011 
                 0.33 
                 0.039 
               
               
                 Combined Analysis 
                 100 
                 0.03 
                 0.003 
                 0.17 
                 0.012 
                 0.64 
                 0.045 
               
               
                   
                 200 
                 0.01 
                 0.003 
                 0.12 
                 0.012 
                 0.37 
                 0.045 
               
               
                   
                 300 
                 0.01 
                 0.003 
                 0.11 
                 0.012 
                 0.37 
                 0.045 
               
               
                   
               
            
           
         
       
     
     Pat expression data (leaves) from the event of the invention from the combined analysis of the 5 locations over a year of cane plant cultivation (Table 10) are shown in  FIG. 11  (in μg protein/g dry tissue). 
     Pat protein expression data from leaves of the event of the invention over a cycle of cane 60 and 120 DAP and cane 240 and 300 DAP at the four evaluated locations are presented in Table 11. 
     
       
         
           
               
             
               
                 TABLE 11 
               
             
            
               
                   
               
               
                 Comparison of average leaf Pat expression from the event of the invention over 
               
               
                 a cane cycle (60 and 120 DAP and 240 and 300 DAP). 
               
            
           
           
               
               
               
            
               
                   
                 Time 
                 Event of the Invention 
               
            
           
           
               
               
               
               
               
               
               
               
            
               
                   
                 DAP/ 
                 μg Pat/ 
                   
                 μg Pat/ 
                   
                 μg Pat/ 
                   
               
               
                 Location 
                 Comparison 
                 mg Total Protein 
                 SE 
                 g Fresh Tissue 
                 SE 
                 g Dry Tissue 
                 SE 
               
               
                   
               
            
           
           
               
               
               
               
               
               
               
               
            
               
                 Barrinha-SP 
                 60 
                 0.011 
                 0.001 
                 0.13 
                 0.010 
                 0.45 
                 0.033 
               
               
                   
                 120 
                 0.016 
                 0.001 
                 0.24 
                 0.010 
                 0.76 
                 0.033 
               
               
                   
                 240 
                 0.017 
                 0.001 
                 0.15 
                 0.010 
                 0.53 
                 0.033 
               
               
                   
                 300 
                 0.018 
                 0.001 
                 0.19 
                 0.010 
                 0.64 
                 0.033 
               
               
                 Piracicaba-SP 
                 60 
                 0.013 
                 0.002 
                 0.14 
                 0.014 
                 0.52 
                 0.041 
               
               
                   
                 120 
                 0.016 
                 0.002 
                 0.21 
                 0.014 
                 0.68 
                 0.041 
               
               
                   
                 240 
                 0.023 
                 0.002 
                 0.23 
                 0.014 
                 0.70 
                 0.041 
               
               
                   
                 300 
                 0.021 
                 0.002 
                 0.19 
                 0.014 
                 0.67 
                 0.041 
               
               
                 Quirinópolis-GO 
                 60 
                 0.011 
                 0.001 
                 0.12 
                 0.010 
                 0.39 
                 0.034 
               
               
                   
                 120 
                 0.009 
                 0.001 
                 0.16 
                 0.010 
                 0.52 
                 0.034 
               
               
                   
                 240 
                 0.015 
                 0.001 
                 0.14 
                 0.010 
                 0.52 
                 0.034 
               
               
                   
                 300 
                 0.017 
                 0.001 
                 0.19 
                 0.010 
                 0.60 
                 0.034 
               
               
                 Valparaíso-SP 
                 60 
                 0.013 
                 0.001 
                 0.14 
                 0.013 
                 0.46 
                 0.045 
               
               
                   
                 120 
                 0.008 
                 0.001 
                 0.12 
                 0.013 
                 0.40 
                 0.045 
               
               
                   
                 240 
                 0.015 
                 0.001 
                 0.12 
                 0.013 
                 0.45 
                 0.045 
               
               
                   
                 300 
                 0.018 
                 0.001 
                 0.20 
                 0.013 
                 0.64 
                 0.045 
               
               
                 Combined Analysis 
                 60 
                 0.012 
                 0.001 
                 0.13 
                 0.009 
                 0.46 
                 0.031 
               
               
                   
                 120 
                 0.012 
                 0.001 
                 0.18 
                 0.009 
                 0.59 
                 0.031 
               
               
                   
                 240 
                 0.017 
                 0.001 
                 0.16 
                 0.009 
                 0.54 
                 0.031 
               
               
                   
                 300 
                 0.018 
                 0.001 
                 0.19 
                 0.009 
                 0.64 
                 0.031 
               
               
                   
               
            
           
         
       
     
     The data from the combined analysis of the 4 evaluated leaf expression locations from the event of the invention over a crop cycle of cane 60 and 120 DAP and cane 240 and 300 DAP (Table 11) are shown in  FIG. 12  (in μg protein/g dry tissue). 
     Pat protein expression data from mature stems of the event of the invention collected at 330 DAP are shown in Table 12. 
     
       
         
           
               
             
               
                 TABLE 12 
               
             
            
               
                   
               
               
                 Comparison of average Pat expression from mature stems of  
               
               
                 the event of the invention harvested at 330 DAP. 
               
            
           
           
               
               
            
               
                   
                 Event of the Invention 
               
            
           
           
               
               
               
               
            
               
                 Location/ 
                 μg Pat/ 
                 μg Pat/ 
                 μg Pat/ 
               
               
                 Comparison 
                 mg Total Protein 
                 g Fresh Tissue 
                 g Dry Tissue 
               
               
                   
               
               
                 Barrinha-SP 
                 0.035 
                 0.014 
                 0.058 
               
               
                 Camamu-BA 
                 0.028 
                 0.013 
                 0.061 
               
               
                 Piracicaba-SP 
                 0.059 
                 0.022 
                 0.087 
               
               
                 Quirinópolis-GO 
                 0.021 
                 0.009 
                 0.035 
               
               
                 Valparaíso-SP 
                 0.034 
                 0.015 
                 0.062 
               
               
                 Standard Error 
                 0.005 
                 0.002 
                 0.006 
               
               
                   
               
            
           
         
       
     
     Bar expression on mature stem of the event of the invention at 330 DAP (Table 12) are shown in  FIG. 13  (in μg protein/g dry tissue). 
     All root samples, from all plots and from all locations, had Cry1Ac protein expression values below the limit of quantification (&lt;LOQ) for the previously validated analysis protocol, except for the Quirinópolis site where an experimental repetition contained 0.053 μg Cry1Ac per gram of fresh tissue. For Pat protein, the results showed that all samples from all plots and locations, without exception, were below the detection limit (&lt;LOD) of the previously validated method (Table 13). 
     
       
         
           
               
             
               
                 TABLE 13 
               
             
            
               
                   
               
               
                 Cry1Ac and Pat protein expression values in root tissues  
               
               
                 of the event of the invention (μ/g fresh tissue). 
               
            
           
           
               
               
               
               
               
            
               
                   
                 Tissue 
                 Location 
                 Cry1Ac 
                 Pat 
               
               
                   
                   
               
               
                   
                 Root 
                 Barrinha-SP 
                 &lt;LOQ 
                 &lt;LOD 
               
               
                   
                   
                 Piracicaba-SP 
                 &lt;LOQ 
                 &lt;LOD 
               
               
                   
                   
                 Valparaiso-SP 
                 &lt;LOQ 
                 &lt;LOD 
               
               
                   
                   
                 Quirinópolis-GO 
                 0.053 1   
                 &lt;LOD 
               
               
                   
                   
                 Camamu-BA 
                 &lt;LOQ 
                 &lt;LOD 
               
               
                   
                   
               
               
                   
                   1 one repetition above LOQ. 
               
            
           
         
       
     
     The results obtained for leaf, stem, and roots indicate that the event of the invention has Cry1Ac protein expression levels much higher than Pat expression. For example, in leaves, the average Cry1Ac expression over sampled times/sites ranged from 26.9 to 33.3 μg/g fresh tissue while mean Pat expression ranged from 0.11 to 0.18 μg/g fresh tissue. The average concentration of Cry1Ac from leaves of the event of the invention throughout the sugarcane cycle remained constant (or slightly decreased) across collection times of 100, 200, and 300 DAP, with concentrations of 26.9, 29.8, and 33.3 μg/g fresh tissue, respectively. Pat expression levels were higher at 100 DAP (0.17 μg/g fresh tissue) and decreased statistically at 200 and 300 DAP with means of 0.12 and 0.11 μg/g fresh tissue, respectively. 
     Leaf expression analysis revealed no relevant protein differences in relation to planting sites. For example, the average expression of Cry1Ac in event leaves of the invention at the five locations ranged from 24.2 to 31.1 μg/g fresh tissue (100 DAP), 22.1 to 35.8 μg/g fresh tissue (200 DAP), and 27.5 to 44.1 μg/g fresh tissue (300 DAP). Corresponding values for Pat expression were: 0.11 to 0.25 μg/g fresh tissue (100 DAP), 0.10 to 0.16 μg/g fresh tissue (200 DAP) and 0.06 to 0.16 μg/g fresh tissue (300 DAP). 
     Stem expression data collected at 330 DAP showed that Cry1Ac and Pat expression levels were 3.65 μg/g fresh tissue and 0.01 μg/g fresh tissue, respectively. The average expression of Cry1Ac at 330 DAP at the five locations ranged from 2.53 to 4.27 μg/g fresh tissue. 
     Expression data of Cry1Ac and Pat proteins in roots of the event of the invention indicate that these proteins are very poorly expressed in this tissue and cannot be accurately identified/quantified. Only the concentration of one repeat Cry1Ac in Quirinópolis was estimated (0.053 μg Cry1Ac per gram of fresh root). All other samples were below the LOD and/or LOQ according to the ELISA methodology employed. 
     The effect of clipping on expression levels was also evaluated. Leaf samples were collected at 60 and 120 DAP, the stems were cut to mimic a crop at 180 DAP, and they were resampled at 60 and 120 days after cutting (or 240 and 300 DAP). The mean combined concentrations of Cry1Ac across sites during these collection periods were 36.2 and 51.1 μg/g (60 and 120 DAP) and 23.1 and 29.2 μg/g fresh tissue (240 and 300 DAP). Pat expression levels were 0.11 and 0.18 (60 and 120 DAP) and 0.16 and 0.19 (240 and 300 DAP). Taken together, the ranges of the Cry1Ac and Pat (bar) protein expression are consistent with the expression data from the previously discussed experiment (100, 200 and 300 DAP) and suggest that the expression levels after shearing are similar to that of expression levels before cutting. 
     The apparent drop in Cry1Ac expression levels after shear, compared to Cry1Ac concentrations before shear, is probably due to sample variability. It is important to note that Cry1Ac expression levels in the previously-described experiment (100, 200 and 300 DAP), which was conducted in parallel with this experiment (in the field and in the laboratory), ranged from 26.9 to 29.8 μg/g fresh tissue. However, Cry1Ac expression levels in this experiment were numerically higher, 36.2 and 51.1 μg/g fresh tissue (60 and 120 DAP), giving the impression of expression drop after cutting. It is known that expression values in various cultures may vary at different sampling times due to experimental variability. The overall conclusion of expression data at 100, 200, and 300 DAP (26.9 to 33.3 μg/g fresh tissue) was replicated at collection points after cutting, 240 to 300 DAP (22.7 to 29.7 μg/g fresh tissue). Higher expression values at 60 and 120 DAP of the sugarcane/cane evaluation experiment can be attributed to the experimental variability and probably do not indicate a significant reduction of Cry1Ac expression levels after cutting the event of the invention. 
     It is therefore concluded that the expression levels of Cry1Ac and Pat proteins from the event of the invention was characterized at different times, tissues and planting sites representative of its cultivation in Brazil. Cry1Ac protein expression levels in the leaves of the event of the invention remain high throughout the cultivation cycle, ensuring the intended effect of resistance to  Diatraea saccharalis . Expression levels of Cry1Ac and Pat proteins in stems from the event of the invention are very low and, therefore, food exposure via consumption of broth or derived products to heterologous proteins will be minimal. 
     Western Blot 
     For identification of the heterologous proteins expressed by the event of the invention, 50 mg of leaf frozen in liquid nitrogen was used. Maceration was performed in the TissueLyser equipment for 10 minutes at 25 Hz, with the addition of three steel beads (3 mm-Qiagen). To the macerated tissue, 750 μl of Tween 20-supplemented saline phosphate extraction buffer (PBS) was added (0.138 M NaCl; 0.027 mM KCl; 0.05% Tween 20, pH 7.4) diluted according to manufacturer&#39;s instructions (Envirologix™, USA). After buffer addition, vortex homogenization was performed, and the mixture was centrifuged for 10 minutes at 9,500 RPM at 4° C. The resulting supernatant was collected and total protein was quantified. 
     Quantitation adopted for analysis of Cry1Ac and Pat proteins was performed according to the recommendations of ThermoScientific™ Coomassie Plus (Bradford) Protein Assay Kit (23236)—Microplate Procedure. Thus, the standards used for obtaining the calibration curve were the already-diluted commercial BSA (Bovine Serum Albumin) standards supplied with the kit described above. The 2000, 1000, 500, 250, 125, and 0 μg/ml calibrators prepared in PBST buffer were used. 10 μL of each standard calibrator was added to the plate wells in triplicate. The plates were covered and incubated for 5 minutes at room temperature. Absorbance was read at 595 nanometers (nm) using SoftmaxPro 7.0 software (Molecular Device). After total protein extraction, 2.5 μg of protein extract was mixed with 2× Laemmli Sample Buffer (Bio-Rad, USA) and subjected to denaturation via heating at 100° C. for 5 minutes. 
     As a negative control of the presence of heterologous proteins, 2.5 μg of protein extract from the conventional parental variety (WT) was used. In addition, positive controls were prepared to detect Cry1Ac and Pat proteins. The first positive control was prepared using either 50 ng CTC internally-purified synthesized Cry1Ac protein or 1 ng commercially-available purified bar protein (Novoprotein, USA), diluted in total protein solution extracted from conventional parental variety (WT) leaves. The second positive control was made by diluting 5 ng of purified Cry1Ac protein (GenScript, USA) or 1 ng of bar protein (Novoprotein, USA) in PBST extraction buffer. Alternatively, other positive controls were added to the assay, such as commercial Bt11 maize and another genetically-modified sugarcane event containing the same proteins upon analysis. 
     Samples were denatured and applied on 4-20% polyacrylamide gel (Mini-PROTEAN® TGXTM Precast Gel) submerged in Tris/glycine/SDS running buffer (Bio-Rad, USA) and separated by electrophoresis at 50V for 5 minutes and then at 120V for approximately 90 minutes. Next, the polyacrylamide gels were equilibrated in Tris/Glycine Transfer Buffer (Bio-Rad, USA), which was added with 20% methanol for 10-15 minutes. The PVDF membrane was treated with absolute methanol. The transfer system was mounted in a container filled with the cold Transfer Buffer for immersion transfer (“wet transfer”) at a constant voltage of 50V for 3 hours. Upon completion of the transfer, the membrane was blocked for 16 hours at 4° C., under constant agitation, in blocking solution [5% skimmed milk powder (Bio-Rad, USA) and TBS/T (20 mM Tris, 150 mM NaCl, 1% Tween20)] to prevent possible nonspecific membrane binding. 
     In the next step, the membrane was incubated with the primary antibody for 90 minutes to detect and confirm the presence and integrity of the Cry1Ac and Pat proteins. The polyclonal antibodies used in this assay were rabbit Anti-Cry1Ab (Fitzgerald, USA), which bind both Cry1Ac and Cry1Ab proteins; and rabbit Anti-Bar (Abcam, USA), which reacts with PAT/Bar protein, diluted 1:100 in TBS/T (v/v). 
     The membrane was washed in 3 5-minute (3×5) cycles in TBS/T and incubated with goat-produced HRP-conjugated secondary Anti-Rabbit antibody (Sigma) at a concentration of 1:20,000 or at a concentration of 1:5,000-v/v (Fitzgerald) for 60 minutes. After incubations, the membrane was again washed with TBS/T (3×5 minutes), and the enzyme-linked immunoassay was verified on Amersham Hyperfilm ECL X-ray films (GE Healthcare, USA) by Clarit Western ECL Substrate Kit substrate reaction (Biorad, USA) according to the manufacturer&#39;s instructions. X-ray film exposure to membrane ranged from 15 seconds to 3 minutes. 
     The results revealed that the expression profile of Cry1Ac protein appears as two nearly-identical molecular weight immunoreactive bands of ˜69 and ˜66 kDa, commonly called doublets, in samples R1 and R2 ( FIG. 14 ). Both samples are biological replicates of the event of the invention, obtained from two experimental plots at the Piracicaba Polo. Protein doublets usually come from the removal of terminal amino acid residues by proteases. As expected, the negative control (NC) in turn showed no immunoreactivity. The negative control consisted of total protein samples extracted from the parental variety. The approximately 69 and 66 kDa bands are also present in positive control 1 (CP1) where the internally purified CT1-purified Cry1Ac protein (50 ng) was added to the total protein extracted from the parental cultivar. Some extra bands of lower molecular weight (between 50 and 30 kDa) are observed in positive control 1 (CP1). These bands are visible, possibly, because the Cry1Ac protein used as a control has been partially purified (34% pure) with other bacterial proteins. Positive control 2 (CP2) consisted of commercial Cry1Ac (5 ng) protein (GeneScript) diluted in PBST extraction buffer. This protein has been isolated with &gt;95% purity and has a single band of the expected weight. 
     Other positive controls have been added to the membrane. A total protein sample extracted from Bt11 corn leaves (Syngenta, USA) was used as a positive control for the experiment (CP3). This is possible because the polyclonal antibodies used in the Western blot assay are also capable of reacting with Cry1Ab proteins. As expected, the Cry1Ab doublet was visible in the Bt11 (CP3) maize sample, as well as other bands at weights of 40 and 30 kDa, accepted as a product of intracellular proteolytic breaks of Cry proteins in plant leaves. Positive control 4 (CP4) consisted of total proteins extracted from another Cry1Ac-expressing sugarcane event. Once again, the profile of the Cry1Ac protein appears as doublet. No other bands indicating partial Cry1Ac protein or higher molecular weight fusion protein were observed in the leaves. 
     The protein encoded by the bar selection gene was also detected by western blot assay. Even though Pat is expressed at lower levels than the Cry1Ac protein, western blot assays demonstrated the presence of an immunoreactive band at the expected size of 22 kDa in all used biological replicates of the event of the invention ( FIG. 15 ). 
     Two positive controls were added to the membrane. Positive control 1 (CP1) corresponds to 1 ng of purified bar protein (Novoprotein, China) diluted in protein extract of the parental cultivar. Positive control 2 (CP2) is the same protein diluted in PBST extraction buffer. The diagnostic band corresponding to the bar protein is present in both controls at the expected height and is identical to the band present at the event of the invention, confirming its identity. 
     In addition to the band corresponding to the Pat protein, it is possible to observe the presence of bands at the approximate weights of 37 kDa and 50 kDa in all samples except the purified protein diluted in the PBST extraction buffer (CP2). The presence of such bands in the positive control 1 is indicative of an artifact, probably generated by nonspecific antibody binding to endogenous sugarcane proteins. 
     It is therefore concluded that the identity of the Cry1Ac and Pat proteins expressed by the event of the invention was confirmed by western blot. The proteins expressed by the event of the invention are of the expected size, and no evidence of truncated/fused proteins being expressed by said event was found. 
     Example 5. Biological Tests: Susceptibility to the Sugarcane Borer ( D. Saccharalis ) 
     Biological Assays (bioassays) with target pest  D. saccharalis  (cane borer) can also be used for detection and characterization of event CTC91087-6, demonstrating the efficacy on the pest control provided by the expressed insecticidal protein Cry1Ac. Different bioassays may be contemplated within the scope of the present invention: for example, Leaf Disk Assay, Screenhouse bioassays, Tissue Dilution Assays, among others. 
     For leaf disc assay, leaves of event CTC91087-6 plants were collected, cut into discs of 16 mm 2  and distributed in bioassay plates containing gelled agar. Each well from culture plates was infested with  D. saccharalis  (0-24 h old) neonate and incubated at 27±1° C., relative humidity 60±10%, and photoperiod 12 h:12 h (light:dark) for a period of 7 days. At the end of incubation, larval mortality and inhibition of larval development of surviving individuals wasevaluated, and the relative efficacy was calculated (Relative efficacy=(1-Mtc/Mev)×100). The surviving larvae were submitted to image analysis by Digimizer software (v 4.6.1) for assessment of larval stage based on width of cephalic capsule. The larvae that did not reach the first instar were considered dead. Non-transgenic sugarcane varieties that are genetically very similar to the evaluated transgenic event can be used as assay controls. 
     To characterize event efficacy in controlling target pest  D. saccharalis  in laboratory, leaf disc assays were performed with plant tissue from CTC91087-6 event (two phenological stages, 110 and 220 DAP). Non-transgenic sugarcane CTC9001 was used as control (WT). The experimental design was completely randomized with four replicates per treatment (112 neonates per replicate). An average of 96% (df=4; P&lt;0.0001) of mortality rate was observed when comparing the conventional variety (CTC9001) and CTC91087-6 event after 7 days feeding with leaf discs. Also, based on measurement of cephalic capsule width, it was observed that 100% of the surviving individuals did not develop beyond the first instar, evidencing high suppression in the development of  D. saccharalis  after feeding with the transgenic event ( FIG. 17 ). 
     For screenhouse bioassays, seedlings of the transgenic event are planted in a screened nursery, where the plants are planted in the soil similar to natural environmental conditions, but in controlled environment to prevent the occurrence of natural infestations. At least 5 infestations are performed every 20 or 30 days, containing 20-35  Diatraea saccharalis  eggs per tiller. The evaluation occurs when all infected stalks are harvested and cutting longitudinally to quantify the damage. Infestation Intensity is calculated dividing the number of internodes with damage by the total number of internodes, and the result was multiplied by 100 (Infestation Intensity). Percentage of Effective Damage was calculated, considering the total of internodes with damage caused by the insect divided by the total number of stalks evaluated in the plot. 
     Screenhouse trials were performed to characterize the efficacy of CTC91087-6 event in controlling borer attack in comparison to its parental variety CTC9001 (WT; non-transgenic) in a randomized block design, with 4 replications. Each experimental plot was composed by eight clumps of cane-plant that received 10 artificial infestations with approximately 30 eggs of  D. saccharalis  every 15 days. After eight months, the Infestation Intensity (II) and the effective Damage for both varieties were calculated. Relative efficacy in controlling infestation and damage by CTC91087-6 event was calculate by the formula [100-(event II*100)/WT II Mean]. 
     Under the artificial infestation the event CTC91087-6 presented relative efficacy in controlling infestation by  D. saccharalis  higher than 99.6% and in controlling stalk damage (length) superior to 99.9% in relation to its non-transgenic parental variety CTC9001 (WT). The damage caused by  D. saccharalis  in CTC91087-6 stalks was visibly lower than in the conventional sugarcane CTC9001 ( FIG. 18 ). There were statistically differences (t-test, P&lt;0.05) between CTC91087-6 and the non-transgenic variety CTC9001 in both parameters evaluated (df=16; P&lt;0.0001), showing that under massive infestation with  D. Saccharalis  the event suppressed the damages caused by the pest. 
     On sugarcane conventional production  D. saccharalis  is considered controlled when the infestation intensity is lower than 3% (Gallo et al., 2002). For CTC91087-6, the intensity of infestation was lower than 0.01% reinforcing the event effectiveness to control its main target pest. 
     In addition to employing bioassays that use artificial infestations to observe the degree of infestation and damage caused by  D. saccharalis , observations of infestation and damage percentage can also be made based on information collected directly from the fields where the event CTC91087-6 is grown. The II (infestation intensity), for example, can be calculated for natural infestation evaluation by defining an experimental area for stalk sampling cutting and quantification the number of internodes with and without damages) to obtain the infestation intensity (II). 
     In the tests performed for the development of the event of the invention, the infestation intensity (II) was calculated in four experimental areas: Piracicaba, Barrinha, and Valparaiso (SP) and Quirinópolis (GO). The conventional variety CTC 9001 (parental; non transgenic) was used as control. This assay illustrates the resistance of the event CTC91087-6 to  D. saccharalis  infestation compared to the parental variety (CTC9001): it was observed a lower intensity of infestation for CTC91087-6 plants in comparison to the parental variety (CTC 9001=WT) in all the four experimental areas (Combined analysis;  FIG. 16 ). 
     Having described examples of preferred embodiments, it should be understood that the scope of the present invention encompasses other possible variations and is limited only by the content of the appended claims, including the possible equivalents thereof.